{"meta":{"query_hash":"4870fd372a71","filters":{"venue":"Medical Oncology"},"cohort_total":86,"direct_labels_cover":4,"predictions_cover":86,"exported":86,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4870fd372a71","api":"https://metacan.xera.ac/api/v1/cohort?venue=Medical+Oncology"},"results":[{"id":"W1964157104","doi":"10.1007/s12032-009-9369-7","title":"Multimodality management for 145 cases of Merkel cell carcinoma","year":2009,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research; University of Windsor; Windsor Regional Hospital; Western University; University of Alberta; University of Saskatchewan","funders":"","keywords":"Medicine; Merkel cell carcinoma; Etoposide; Carboplatin; Irinotecan; Internal medicine; Chemotherapy; Surgery; Medical record; Topotecan; Oncology; Carcinoma; Cisplatin; Cancer; Colorectal cancer","score_opus":0.02492328467879471,"score_gpt":0.3480371038444179,"score_spread":0.32311381916562315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964157104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196446,0.0033588025,0.0011126825,0.000117910844,0.000026588132,0.000063443826,0.00013565074,0.000025394562,0.0031950092],"genre_scores_gemma":[0.9984112,0.00059093337,0.00050177245,0.000055690583,0.000021869455,0.000020663823,0.00012175768,0.000006559473,0.00026943933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997502,0.00004417475,0.000045610577,0.000047279103,0.000050335828,0.00006235357],"domain_scores_gemma":[0.999762,0.000078582736,0.00006090551,0.000024241952,0.000021393958,0.0000528554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046858797,0.00047348544,0.00040765508,0.0012572064,0.0010412793,0.0005414519,0.00043327906,0.00045026792,0.0011159207],"category_scores_gemma":[0.0011809117,0.0004035754,0.0006523289,0.0007500041,0.0004574506,0.00049509545,0.0008624283,0.0003290545,0.00019001341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013272214,0.00025717437,0.73145205,0.00037348847,0.00020904042,0.18069656,0.0016194715,0.0019346451,0.019223325,0.0004784328,0.0011221903,0.061306376],"study_design_scores_gemma":[0.00017827736,0.002153061,0.641289,0.00015803629,0.00038314846,0.33483684,0.0013227443,0.0035907102,0.009605652,0.00044210668,0.0059686033,0.0000719145],"about_ca_topic_score_codex":0.0015815994,"about_ca_topic_score_gemma":0.0031936348,"teacher_disagreement_score":0.0015815994,"about_ca_system_score_codex":0.0006213641,"about_ca_system_score_gemma":0.00041249348,"threshold_uncertainty_score":0.0045083165},"labels":[],"label_agreement":null},{"id":"W1964578384","doi":"10.1007/s12032-010-9528-x","title":"Natural products and their role in cancer therapy","year":2010,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer; Natural (archaeology); Medicine; Adjuvant; Hematology; Side effect (computer science); Natural medicine; Cancer therapy; Intensive care medicine; Traditional medicine; Internal medicine; Biology; Computer science","score_opus":0.02317993644216093,"score_gpt":0.3416249848740942,"score_spread":0.3184450484319333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964578384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021967123,0.9962016,0.0004684572,0.0002249372,0.00030932258,0.000008861898,0.000018971286,0.000009123572,0.0025389716],"genre_scores_gemma":[0.001756693,0.9953418,0.0005379865,0.00017993922,0.0002515827,0.000014400155,0.000030657935,0.0000020626217,0.0018849153],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986804,0.000024049108,0.000012474252,0.000020538222,0.000058167578,0.000016646307],"domain_scores_gemma":[0.9998623,0.00006159795,0.00002181642,0.000006835665,0.000032797772,0.000014649534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005142713,0.0008788816,0.0009501944,0.0013215314,0.0002955063,0.0008808194,0.000709112,0.00085004757,0.0033686147],"category_scores_gemma":[0.00041477196,0.0003021882,0.00030093952,0.0017598011,0.0007163491,0.0010670521,0.0006119743,0.0018519572,0.0019141072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001245499,0.00013663458,0.00011810053,0.0064943377,0.00005280206,0.00027198883,0.000046608413,0.00068147166,0.008837059,0.009147341,0.027663311,0.9464259],"study_design_scores_gemma":[0.000029458564,0.00007523678,0.00026582967,0.00060237997,0.00004242644,0.00069432135,0.000028748946,0.000109076296,0.0014945213,0.0026946575,0.9939528,0.0000104399],"about_ca_topic_score_codex":0.0009180659,"about_ca_topic_score_gemma":0.0020686963,"teacher_disagreement_score":0.0033686147,"about_ca_system_score_codex":0.00069703395,"about_ca_system_score_gemma":0.0008532697,"threshold_uncertainty_score":0.011269152},"labels":[],"label_agreement":null},{"id":"W1974549193","doi":"10.1007/s12032-010-9704-z","title":"Squamous cell carcinoma of the renal pelvis associated with kidney stones: a case report","year":2010,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grace (Canada)","funders":"","keywords":"Medicine; Squamous metaplasia; Nephrectomy; Differential diagnosis; Renal cell carcinoma; Kidney; Malignancy; Kidney stones; Renal pelvis; Urology; Abdominal mass; Kidney disease; Hematology; Pathology; Radiology; Internal medicine; Epithelium","score_opus":0.03463733054188251,"score_gpt":0.34983016842503917,"score_spread":0.31519283788315666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974549193","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035224963,0.95395327,0.0012999367,0.001989927,0.0006853933,0.000057140784,0.00016118475,0.00008139681,0.0065468485],"genre_scores_gemma":[0.1411501,0.84962106,0.0019297967,0.0016177873,0.0020335438,0.000016263866,0.0002182187,0.000014998415,0.0033981935],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99974686,0.000029775036,0.000054565262,0.000059291015,0.00006474356,0.000044745477],"domain_scores_gemma":[0.99954045,0.00018348452,0.00013669106,0.000025910713,0.000047971178,0.00006544913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021119697,0.0012852522,0.0013816317,0.002659856,0.00070376653,0.0015973762,0.0013579592,0.0029235205,0.0023353214],"category_scores_gemma":[0.0008291273,0.0005839524,0.0008638913,0.002570428,0.0009175609,0.0025359483,0.00095010333,0.0011247842,0.00092482346],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006985991,0.0001369635,0.007198751,0.0047381395,0.00018520524,0.83440834,0.0003463282,0.0002894627,0.0038368902,0.0005079236,0.0101543795,0.13812783],"study_design_scores_gemma":[0.000014161266,0.000050437793,0.005463103,0.00069985486,0.00028709075,0.9591013,0.00039599597,0.00014465002,0.00074074516,0.00034279877,0.032723654,0.00003617337],"about_ca_topic_score_codex":0.0019271941,"about_ca_topic_score_gemma":0.0050044945,"teacher_disagreement_score":0.0029235205,"about_ca_system_score_codex":0.00053826283,"about_ca_system_score_gemma":0.0012009465,"threshold_uncertainty_score":0.007812381},"labels":[],"label_agreement":null},{"id":"W1979571949","doi":"10.1007/s12032-009-9303-z","title":"Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET","year":2009,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Hospital Foundation","funders":"","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Internal medicine; Hazard ratio; Placebo; Oncology; Cytokine; Kidney cancer; Confidence interval; Gastroenterology; Hepatocellular carcinoma; Pathology","score_opus":0.008199493033392145,"score_gpt":0.2573436654551726,"score_spread":0.24914417242178047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979571949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989844,0.0005506764,0.000064059,0.000021826718,0.000004279792,0.0000162584,0.0001193397,0.0000035382932,0.00023552206],"genre_scores_gemma":[0.99926,0.00015212529,0.000038176713,0.000036466397,0.000018719198,0.000013589018,0.00032820477,0.0000023132843,0.00015033662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993315,0.00024037613,0.00005782638,0.00012344142,0.00012681012,0.00012024636],"domain_scores_gemma":[0.9992157,0.00029185807,0.0002058417,0.000083142586,0.000060017082,0.00014338882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008230378,0.00037052977,0.0013816481,0.00039727124,0.00024081799,0.00050793256,0.00021853004,0.0003191476,0.000987679],"category_scores_gemma":[0.0011873748,0.00017026793,0.0013635688,0.00054941187,0.00034789476,0.00040976936,0.00026055062,0.00060439477,0.00015045948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29430848,0.0038867062,0.56820303,0.0004912758,0.007993601,0.00061285676,0.0004148683,0.0033307322,0.028519046,0.00021573143,0.0011189753,0.09090467],"study_design_scores_gemma":[0.012923942,0.05138603,0.92204404,0.000017656317,0.0035308274,0.0013443336,0.00022024004,0.0022984168,0.003947316,0.00023059858,0.002020068,0.00003655248],"about_ca_topic_score_codex":0.0006249508,"about_ca_topic_score_gemma":0.0012201879,"teacher_disagreement_score":0.0013816481,"about_ca_system_score_codex":0.00048754475,"about_ca_system_score_gemma":0.000426281,"threshold_uncertainty_score":0.004352689},"labels":[],"label_agreement":null},{"id":"W1991636528","doi":"10.1007/s12032-008-9111-x","title":"A phase I clinical study of intratumorally administered VB4-845, an anti-epithelial cell adhesion molecule recombinant fusion protein, in patients with squamous cell carcinoma of the head and neck","year":2008,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Viventia Bio (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Head and neck squamous-cell carcinoma; Immunogenicity; Head and neck cancer; Epithelial cell adhesion molecule; Adverse effect; Hematology; Internal medicine; Pharmacodynamics; Cell adhesion molecule; Oncology; Urology; Gastroenterology; Radiation therapy; Cancer; Immunology; Antibody","score_opus":0.019808718712518245,"score_gpt":0.2869624698492978,"score_spread":0.2671537511367795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991636528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942145,0.001374915,0.0006299549,0.0003234386,0.00011229903,0.0012296623,0.0003660059,0.000058711306,0.0016906172],"genre_scores_gemma":[0.9936413,0.0013202474,0.00083724974,0.0003829451,0.00008025215,0.00094921654,0.00071905914,0.000016905975,0.002052715],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99969494,0.000109276545,0.0000087709295,0.000054623186,0.000022440283,0.000109962224],"domain_scores_gemma":[0.9996257,0.00008113601,0.000044785815,0.00004063478,0.00002530898,0.00018248797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009053244,0.0012737797,0.0017706578,0.00039906963,0.0005502905,0.00092723523,0.0008044664,0.0013939044,0.0022363618],"category_scores_gemma":[0.0005097329,0.00052380865,0.0010196238,0.0004037711,0.0011782398,0.00061003014,0.00024249787,0.0024495602,0.00065694173],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48276913,0.16672648,0.013178215,0.0010516299,0.0016362569,0.0011193043,0.0011024383,0.0066567324,0.18251805,0.0011592989,0.005526825,0.13655567],"study_design_scores_gemma":[0.21815062,0.7533396,0.0112038,0.00003132137,0.00049515936,0.0004995036,0.00018689748,0.0017455384,0.011096133,0.00023169682,0.0029898451,0.000029947803],"about_ca_topic_score_codex":0.003079084,"about_ca_topic_score_gemma":0.00453734,"teacher_disagreement_score":0.003079084,"about_ca_system_score_codex":0.0009925115,"about_ca_system_score_gemma":0.0015347126,"threshold_uncertainty_score":0.007481396},"labels":[],"label_agreement":null},{"id":"W1995186012","doi":"10.1007/bf02782203","title":"Metastatic small cell lung cancer causing biliary obstruction","year":2000,"lang":"en","type":"letter","venue":"Medical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Hematology; Medicine; Internal medicine; Lung cancer; Cancer; Lung; Oncology; Pathology; Gastroenterology","score_opus":0.03543595184754819,"score_gpt":0.37197979487661736,"score_spread":0.33654384302906915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995186012","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02109609,0.0061613913,0.00056791195,0.8901453,0.030364022,0.00012400742,0.00017231032,0.00009677022,0.051272213],"genre_scores_gemma":[0.1625864,0.009716385,0.0012455102,0.640746,0.1287324,0.00016050492,0.0002610953,0.00010155417,0.056450125],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993795,0.0001682866,0.00006935767,0.000076930686,0.00013685021,0.0001689902],"domain_scores_gemma":[0.9982198,0.0009984705,0.0001796401,0.00008575518,0.00017862451,0.00033764404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078008714,0.00094670313,0.0011044856,0.0008982941,0.0028117239,0.0023693577,0.0013631515,0.046212766,0.006785804],"category_scores_gemma":[0.0090904,0.00085340545,0.0013615835,0.00089571846,0.001721015,0.002329524,0.0012142134,0.018128598,0.0028629315],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004029203,0.00015141578,0.009545577,0.00026073828,0.000092260736,0.54360336,0.00048988,0.00052172475,0.0012133848,0.006480634,0.42235717,0.0148808975],"study_design_scores_gemma":[0.0009503235,0.000704583,0.015729496,0.0007736936,0.00035717717,0.45735678,0.0015755866,0.0054711723,0.0016731421,0.015037328,0.50024194,0.0001287231],"about_ca_topic_score_codex":0.0027689715,"about_ca_topic_score_gemma":0.006706817,"teacher_disagreement_score":0.046212766,"about_ca_system_score_codex":0.003657404,"about_ca_system_score_gemma":0.0011590956,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W1999874526","doi":"10.1007/s12032-011-0114-7","title":"Reduced expression of activin receptor-like kinase 7 in breast cancer is associated with tumor progression","year":2011,"lang":"en","type":"article","venue":"Medical Oncology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Natural Science Foundation of China","keywords":"Breast cancer; Fibroadenoma; Medicine; Ductal carcinoma; Cancer; Internal medicine; Immunohistochemistry; Oncology; CA 15-3; Tissue microarray; Progesterone receptor; Phyllodes tumor; Breast Fibroadenoma; Cancer research; Pathology; Estrogen receptor; CA15-3","score_opus":0.01574418438219454,"score_gpt":0.3048982107910256,"score_spread":0.28915402640883103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999874526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977308,0.00096801587,0.00042352546,0.00006363639,0.0000107848655,0.0000038007702,0.00016215275,0.000033160093,0.0006041442],"genre_scores_gemma":[0.9978654,0.00041036788,0.00023919194,0.000021258991,0.000015003585,0.000007875232,0.00029544628,0.0000075796347,0.001138048],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998822,0.000021964954,0.000010590525,0.000020250973,0.00003775461,0.000027185093],"domain_scores_gemma":[0.9994685,0.00008634973,0.00023997981,0.000038790364,0.000054730634,0.00011175349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016777556,0.00013538775,0.00024192264,0.0009339543,0.00018720048,0.0003881712,0.00017301805,0.00028128325,0.0021815319],"category_scores_gemma":[0.00038345094,0.00019165705,0.00020409141,0.00051123527,0.00024528947,0.00013631395,0.00016038623,0.00060250855,0.00038656025],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032847035,0.0001820125,0.08004759,0.00006159063,0.00007866668,0.0008740667,0.00006579175,0.0001446743,0.907825,0.00028856474,0.00027824272,0.0068690283],"study_design_scores_gemma":[0.000061294224,0.0005928756,0.8007552,0.000010506606,0.00016099699,0.0055010268,0.0001912627,0.0017732477,0.18708809,0.0005038645,0.003348963,0.0000127428775],"about_ca_topic_score_codex":0.00031916736,"about_ca_topic_score_gemma":0.00024286349,"teacher_disagreement_score":0.0021815319,"about_ca_system_score_codex":0.00016279213,"about_ca_system_score_gemma":0.0001847717,"threshold_uncertainty_score":0.007297933},"labels":[],"label_agreement":null},{"id":"W2001364692","doi":"10.1007/s12032-009-9184-1","title":"Proteomic analysis of the stroma-related proteins in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues","year":2009,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Oral and Maxillofacial Pathology","field":"Dentistry","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Stroma; Nasopharyngeal carcinoma; Stromal cell; Biology; Carcinogenesis; Pathology; Laser capture microdissection; Metastasis; Immunohistochemistry; Cancer research; Microdissection; Population; Proteomics; Epithelium; Cancer; Immunology; Medicine; Internal medicine; Radiation therapy; Gene expression; Gene; Biochemistry","score_opus":0.012004129563700705,"score_gpt":0.286297457210366,"score_spread":0.27429332764666525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001364692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950949,0.0015493204,0.0009102953,0.00006390563,0.00003581251,0.000020887697,0.00046060566,0.0000156662,0.0018485307],"genre_scores_gemma":[0.99062294,0.0018768829,0.002044336,0.00008218231,0.000040089144,0.000048664533,0.0020156607,0.00001160616,0.003257638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988246,0.000015189978,0.000011533201,0.000018942888,0.000043476728,0.000028346481],"domain_scores_gemma":[0.999869,0.000027234348,0.000012445746,0.000010002746,0.000050347764,0.00003111512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001743853,0.00026108822,0.00028182307,0.000558254,0.00056678953,0.00031526134,0.00020612097,0.0001720952,0.0013659273],"category_scores_gemma":[0.0002905448,0.00012959277,0.00028703408,0.0005071181,0.00018408694,0.00024005506,0.0002580298,0.0002496611,0.00041776357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063087046,0.000037055404,0.0044738976,0.00010967161,0.000039383023,0.0004883075,0.000087916946,0.00005088917,0.99127793,0.00011145001,0.00010723012,0.0025854625],"study_design_scores_gemma":[0.000050991723,0.00071185397,0.27833167,0.000022292192,0.00027275388,0.006954359,0.0011941588,0.0028079785,0.69828236,0.0002791632,0.0110708475,0.000021469044],"about_ca_topic_score_codex":0.0012708894,"about_ca_topic_score_gemma":0.001104222,"teacher_disagreement_score":0.0013659273,"about_ca_system_score_codex":0.00018547564,"about_ca_system_score_gemma":0.00029233532,"threshold_uncertainty_score":0.004569471},"labels":[],"label_agreement":null},{"id":"W2001391041","doi":"10.1007/s12032-014-0942-3","title":"No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case–control study","year":2014,"lang":"en","type":"article","venue":"Medical Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute for Catastrophic Loss Reduction","keywords":"XRCC3; Biology; Genetics; Population; Genotype; Colorectal cancer; Oncology; Allele; Xeroderma pigmentosum; Internal medicine; DNA repair; Single-nucleotide polymorphism; Cancer; Gene; Medicine; Environmental health","score_opus":0.004819191493151929,"score_gpt":0.2649353875199924,"score_spread":0.2601161960268405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001391041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999273,0.00032419417,0.000078786165,0.000025542926,0.0000052480978,0.000004915812,0.00009319276,0.000001656899,0.00019339936],"genre_scores_gemma":[0.9993241,0.0001446692,0.000085834,0.00002244681,0.0000098367545,0.000005991376,0.00010637159,0.000002085779,0.00029859834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958426,0.000087234344,0.000056336907,0.00014275323,0.000063087486,0.000066335786],"domain_scores_gemma":[0.9995352,0.000108086635,0.00017458186,0.000060680046,0.000056347413,0.00006509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005737531,0.00045038556,0.0006157626,0.0006019409,0.00065768714,0.00063555,0.00045651302,0.0004933385,0.002589432],"category_scores_gemma":[0.0008902098,0.00045805037,0.0005581944,0.0008908161,0.0003688179,0.0002911779,0.00023692241,0.00034727083,0.0001901332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010634821,0.00015204838,0.9927267,0.00004393173,0.0005005211,0.00087309215,0.0003226354,0.000052626652,0.0019636087,0.00006793322,0.00012858749,0.0021047771],"study_design_scores_gemma":[0.00003686174,0.00024347157,0.99725777,0.000007548978,0.00029216197,0.0011764694,0.0002249602,0.00019934474,0.00018221689,0.000035265082,0.00033826224,0.000005812014],"about_ca_topic_score_codex":0.010743506,"about_ca_topic_score_gemma":0.0090761855,"teacher_disagreement_score":0.010743506,"about_ca_system_score_codex":0.00037939107,"about_ca_system_score_gemma":0.00028835094,"threshold_uncertainty_score":0.021361947},"labels":[],"label_agreement":null},{"id":"W2006381120","doi":"10.1385/mo:23:2:273","title":"Dendritic Cells, Pulsed with Lysate of Allogeneic Tumor Cells, Are Capable of Stimulating MHC-Restricted Antigen-Specific Antitumor T Cells","year":2006,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Antigen; Cytotoxic T cell; ELISPOT; Biology; Antigen-presenting cell; Major histocompatibility complex; CD8; Cancer research; MHC class I; Immunology; T cell; Chemistry; Immune system; In vitro; Biochemistry","score_opus":0.010771433519101306,"score_gpt":0.2367423239489486,"score_spread":0.22597089042984728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006381120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833935,0.00310103,0.00579688,0.00037395288,0.00039184617,0.00008563601,0.00035700397,0.00014590855,0.006354141],"genre_scores_gemma":[0.992174,0.001807249,0.002433149,0.00018688757,0.00021766014,0.000053697593,0.0007380259,0.00003440758,0.002354865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974626,0.000049054575,0.000016002756,0.00004127541,0.00006879914,0.00007862363],"domain_scores_gemma":[0.99965084,0.00014400612,0.000050533792,0.000049137165,0.000029975708,0.00007540644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027025852,0.00067175686,0.00052177254,0.00034212528,0.00018411643,0.00050820323,0.00016720923,0.00058485137,0.0012975315],"category_scores_gemma":[0.00037679734,0.00023887446,0.0003504974,0.00023229823,0.00026948634,0.0002082922,0.00027093443,0.0012491869,0.00085151085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006812507,0.00019462156,0.0005827132,0.000089472705,0.000017762752,0.00013829142,0.000016934908,0.00023626798,0.99264306,0.0002440738,0.00029019278,0.004865419],"study_design_scores_gemma":[0.00028863535,0.0008343104,0.0024883915,0.000013724922,0.00006296063,0.00080479507,0.000029365401,0.0019754146,0.98794764,0.00039268256,0.0051531624,0.000008852707],"about_ca_topic_score_codex":0.0000959914,"about_ca_topic_score_gemma":0.0001344641,"teacher_disagreement_score":0.0012975315,"about_ca_system_score_codex":0.00019731517,"about_ca_system_score_gemma":0.00021612534,"threshold_uncertainty_score":0.0043407083},"labels":[],"label_agreement":null},{"id":"W2007318414","doi":"10.1007/s12032-012-0380-z","title":"Junctional adhesion molecules 2 and 3 may potentially be involved in progression of gastric adenocarcinoma tumors","year":2012,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Tarbiat Modares University; Stem Cell Network","keywords":"Gene; Biology; Adenocarcinoma; Cancer; Cancer research; Tight junction; Hematology; Pathological; Gene expression; Cell adhesion molecule; Pathology; Cell biology; Immunology; Medicine; Genetics","score_opus":0.036986116279162866,"score_gpt":0.3146563706079237,"score_spread":0.2776702543287608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007318414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273175,0.0044865753,0.00079635775,0.00013307623,0.000013380535,0.000021988644,0.00005211002,0.00001847569,0.0017462948],"genre_scores_gemma":[0.9974485,0.0010975521,0.000454194,0.00004992688,0.000009026318,0.000017188622,0.00007282853,0.000002037433,0.0008487565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991155,0.000027093438,0.0000050282797,0.000009518576,0.000016305927,0.000030491297],"domain_scores_gemma":[0.99990773,0.0000146381335,0.000035774803,0.000005772202,0.000015200158,0.000020827652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002538711,0.00022901509,0.00022840603,0.0005120953,0.00029149093,0.0003614217,0.0002609934,0.0004152938,0.0010652448],"category_scores_gemma":[0.00030397013,0.0001156784,0.0002186941,0.00023508852,0.00020029879,0.0004665407,0.0002610646,0.00048154732,0.00009656705],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016934793,0.000294158,0.039383277,0.00023746766,0.00012995189,0.0020940385,0.00034177265,0.00053994195,0.9297028,0.0034028147,0.00042116723,0.02175903],"study_design_scores_gemma":[0.00016828877,0.0022883355,0.6542479,0.00007218474,0.00040376768,0.004006567,0.0013111111,0.006534901,0.31319118,0.00361459,0.014114266,0.00004693107],"about_ca_topic_score_codex":0.0017496705,"about_ca_topic_score_gemma":0.001541008,"teacher_disagreement_score":0.0017496705,"about_ca_system_score_codex":0.00031130837,"about_ca_system_score_gemma":0.00024654483,"threshold_uncertainty_score":0.0035636425},"labels":[],"label_agreement":null},{"id":"W2009689366","doi":"10.1007/s12032-013-0582-z","title":"Factors influencing the willingness of US women to vaccinate their daughters against the human papillomavirus to prevent cervical cancer","year":2013,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cervical cancer; Human papillomavirus; Medicine; Logistic regression; Demography; Psychological intervention; Health Information National Trends Survey; Family medicine; Cancer; Gynecology; Internal medicine; Health care; Nursing; Health information","score_opus":0.04331435840010408,"score_gpt":0.3758634120718248,"score_spread":0.3325490536717207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009689366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972115,0.000102930484,0.000020908206,0.00047606698,0.0000072835282,0.000005890354,0.000042775802,9.268962e-7,0.0021316663],"genre_scores_gemma":[0.99946946,0.000074391,0.000026671316,0.00012324167,0.0000065647478,0.000003817821,0.000023543816,0.0000013926355,0.00027109563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999388,0.00033529598,0.00003965241,0.000041056785,0.000077270015,0.000118629985],"domain_scores_gemma":[0.9934018,0.0037224027,0.0015869435,0.00021909982,0.00036824768,0.0007013247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010155418,0.00010271235,0.00013242076,0.0003798675,0.0004964955,0.00094390917,0.00022393973,0.00063306146,0.006429032],"category_scores_gemma":[0.011581691,0.00014850378,0.00027088332,0.000457261,0.00046944816,0.00031322739,0.0002825705,0.0008042131,0.0003437911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028759125,0.00021172185,0.99293023,0.000013323129,0.00005267425,0.00016859056,0.0013230996,0.00004541961,0.0003472084,0.00015449214,0.00038048634,0.004085261],"study_design_scores_gemma":[0.000020332362,0.0001842542,0.98916376,0.000030337658,0.000051131447,0.0004875383,0.007510437,0.00034447946,0.00021477457,0.00016336118,0.0018205938,0.000009071515],"about_ca_topic_score_codex":0.0052723032,"about_ca_topic_score_gemma":0.0057145134,"teacher_disagreement_score":0.006429032,"about_ca_system_score_codex":0.00029534404,"about_ca_system_score_gemma":0.0005043578,"threshold_uncertainty_score":0.021507323},"labels":[],"label_agreement":null},{"id":"W2014509452","doi":"10.1007/s12032-014-0111-8","title":"Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population","year":2014,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Genotype; Odds ratio; Minor allele frequency; Allele; Breast cancer; Internal medicine; Genetics; Population; Case-control study; Medicine; Allele frequency; Oncology; Biology; Cancer; Gene; Environmental health","score_opus":0.007170706706336607,"score_gpt":0.2750495070381521,"score_spread":0.2678788003318155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014509452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995221,0.00010863871,0.00007329945,0.000065841516,0.0000050724534,0.0000022469176,0.000040303345,0.0000018175472,0.00018072406],"genre_scores_gemma":[0.99942505,0.00008504972,0.000100147045,0.0000346719,0.000016934695,0.000005476488,0.000060592574,0.0000016376416,0.00027042488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980897,0.000057802827,0.000017698236,0.000050972205,0.00002363403,0.000041067928],"domain_scores_gemma":[0.99973994,0.00006916428,0.00008208098,0.000019607836,0.000036426092,0.00005266334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029387925,0.0003507516,0.00028285375,0.00092479785,0.0007186096,0.00038960422,0.00035390066,0.00037864872,0.002483095],"category_scores_gemma":[0.0007251681,0.0002832961,0.0004985903,0.0010624187,0.00035294614,0.00019369423,0.00021896053,0.0005009782,0.00019427501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063611113,0.00019280241,0.9899003,0.000019012463,0.00022043161,0.00067752245,0.0006273569,0.000090824564,0.0031829257,0.0001503329,0.00021695123,0.004085613],"study_design_scores_gemma":[0.00004112792,0.00026621163,0.99699223,0.000006537245,0.00016020561,0.00094978354,0.0006225973,0.00037470745,0.0001766209,0.000098009834,0.0003057967,0.000006207031],"about_ca_topic_score_codex":0.007866782,"about_ca_topic_score_gemma":0.0052333227,"teacher_disagreement_score":0.007866782,"about_ca_system_score_codex":0.00026249673,"about_ca_system_score_gemma":0.00028296732,"threshold_uncertainty_score":0.015641987},"labels":[],"label_agreement":null},{"id":"W2016776460","doi":"10.1007/s12032-011-0076-9","title":"Leptomeningeal carcinomatosis from ovarian cancer","year":2011,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Medicine; Ovarian cancer; Meningeal carcinomatosis; Cancer; Parenchyma; Peritoneal carcinomatosis; Chemotherapy; Cause of death; Hematology; Pathology; Cerebrum; Internal medicine; Oncology; Disease; Central nervous system; Cerebrospinal fluid; Colorectal cancer","score_opus":0.1196515121542932,"score_gpt":0.42533993876677745,"score_spread":0.30568842661248424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016776460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019392824,0.9985752,0.00006321697,0.00015404128,0.00012730731,0.000004943519,0.000019743833,0.0000039697634,0.00085758104],"genre_scores_gemma":[0.0014582594,0.9975756,0.000090794936,0.00020931715,0.00018128645,0.000004817594,0.000030933046,0.0000010563449,0.00044795056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999871,0.000025353658,0.00003102919,0.000019891206,0.00003954854,0.000013119266],"domain_scores_gemma":[0.9997055,0.00013661249,0.00008114875,0.0000089132245,0.000047086112,0.000020744115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028570092,0.000758734,0.0014191273,0.0026141729,0.00022658877,0.00081876444,0.000549547,0.0006680943,0.0035396433],"category_scores_gemma":[0.00090675923,0.00028580963,0.00044977566,0.0025818876,0.00042665092,0.001024385,0.00058047636,0.0009578217,0.0008795513],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009295761,0.000038511655,0.00038080214,0.029800907,0.000163763,0.0009782914,0.000047409016,0.000279338,0.0011238259,0.0007324333,0.029506303,0.9368555],"study_design_scores_gemma":[0.000095634394,0.0001836887,0.0032776312,0.011932641,0.00090932456,0.013339891,0.00013465728,0.0001502421,0.00087783794,0.0010477537,0.9680104,0.000040258114],"about_ca_topic_score_codex":0.0019030002,"about_ca_topic_score_gemma":0.0068031545,"teacher_disagreement_score":0.0035396433,"about_ca_system_score_codex":0.00057949265,"about_ca_system_score_gemma":0.0010027484,"threshold_uncertainty_score":0.011841297},"labels":[],"label_agreement":null},{"id":"W2016846579","doi":"10.1007/s12032-013-0561-4","title":"Appropriateness of cardiovascular care in elderly adult cancer survivors","year":2013,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacy; Myocardial infarction; Internal medicine; Poisson regression; Cancer; Bypass surgery; Emergency medicine; Psychological intervention; Intensive care medicine; Population; Family medicine","score_opus":0.02279055953838252,"score_gpt":0.32088968285171976,"score_spread":0.2980991233133372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016846579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972072,0.00071892433,0.00006446741,0.00034451362,0.000018497387,0.000010144782,0.00018597687,0.0000031301443,0.0014470441],"genre_scores_gemma":[0.99937147,0.0002036568,0.00006709409,0.00011239062,0.000027219525,0.0000044474205,0.0001291052,8.662548e-7,0.00008391203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989901,0.00030858335,0.00029901852,0.00008297048,0.00021463842,0.00010472899],"domain_scores_gemma":[0.9964527,0.0008904667,0.001702367,0.00012470371,0.00040715263,0.00042257065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070580735,0.0001265857,0.00039008123,0.00063297217,0.00047541835,0.00063215854,0.00016678266,0.0005993345,0.00095764245],"category_scores_gemma":[0.0079223355,0.00014221513,0.0005639789,0.00090609037,0.0001698183,0.00043342425,0.0003761212,0.00059356214,0.00010871358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004627835,0.0000320181,0.99794096,0.000010168846,0.000041473202,0.00007860375,0.000090690744,0.000024482191,0.000028824741,0.000009908723,0.00006488382,0.0016317392],"study_design_scores_gemma":[0.000004852433,0.00010928418,0.9986451,0.000016663855,0.000043483138,0.00031200706,0.00042366603,0.00023255002,0.00003205818,0.00003205056,0.00014418704,0.0000041539033],"about_ca_topic_score_codex":0.006749307,"about_ca_topic_score_gemma":0.01408449,"teacher_disagreement_score":0.006749307,"about_ca_system_score_codex":0.00042272787,"about_ca_system_score_gemma":0.00054132496,"threshold_uncertainty_score":0.013420045},"labels":[],"label_agreement":null},{"id":"W2023276278","doi":"10.1007/s12032-015-0490-5","title":"ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins","year":2015,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"HeLa; Apoptosis; Cell cycle; Cell growth; MAPK/ERK pathway; Flow cytometry; Cancer research; Cell; Kinase; Western blot; Biology; Cancer; Cancer cell; Molecular biology; Chemistry; Cell biology; Biochemistry; Gene; Genetics","score_opus":0.019487647846426464,"score_gpt":0.285930108448547,"score_spread":0.2664424606021205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023276278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866214,0.0037170425,0.001840517,0.00025409053,0.00008151017,0.000057530775,0.0005545507,0.00008736212,0.006785991],"genre_scores_gemma":[0.98864204,0.0024201293,0.00073903165,0.000071786526,0.000022803824,0.00004022111,0.00053696014,0.000009874597,0.0075171357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999356,0.000008642532,0.0000034188672,0.00000754381,0.00001571622,0.00002901393],"domain_scores_gemma":[0.9999746,0.0000033474555,0.0000040150967,0.0000033991066,0.0000074520967,0.0000071329687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009061201,0.00040508673,0.00018053579,0.000408369,0.0002434203,0.00015655886,0.00012669594,0.00014496021,0.0025448133],"category_scores_gemma":[0.000064269516,0.00010810088,0.00026224655,0.00019559542,0.0001332504,0.00013451939,0.0001275767,0.0005265566,0.00043326296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035435654,0.00016056596,0.00040008777,0.00013474179,0.000010902014,0.000120119315,0.000031860247,0.000103468075,0.9923119,0.00030669942,0.0002533969,0.005811788],"study_design_scores_gemma":[0.00006858732,0.00047948473,0.008671366,0.00001173441,0.000037678674,0.00060781714,0.00006707937,0.00092722866,0.98096174,0.00020227896,0.007957733,0.0000072121998],"about_ca_topic_score_codex":0.0008087264,"about_ca_topic_score_gemma":0.0016520134,"teacher_disagreement_score":0.0025448133,"about_ca_system_score_codex":0.00021923333,"about_ca_system_score_gemma":0.0003164324,"threshold_uncertainty_score":0.008513272},"labels":[],"label_agreement":null},{"id":"W2024248750","doi":"10.1007/s12032-010-9639-4","title":"Presentation and outcomes of patients aged 30 years and younger with colorectal cancer: a 20-year retrospective review","year":2010,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Colorectal cancer; Stage (stratigraphy); Internal medicine; Cancer; Cohort; Family history; Disease; Retrospective cohort study","score_opus":0.00967968633641504,"score_gpt":0.31982454780139047,"score_spread":0.31014486146497544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024248750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98511606,0.01269433,0.00008169701,0.00009197398,0.000017855835,0.000011333657,0.0010190831,0.00000494823,0.0009626087],"genre_scores_gemma":[0.99058175,0.007879712,0.00007668562,0.000086953805,0.000031483425,0.000010129488,0.0011544054,0.000003869771,0.00017498524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996246,0.000055430504,0.0000973424,0.00007944219,0.00007184742,0.00007130965],"domain_scores_gemma":[0.9987833,0.00025477886,0.0006430447,0.00004750007,0.00012808201,0.00014328823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034269132,0.00018983449,0.00055437314,0.0014913284,0.0003649385,0.00053032703,0.0002833034,0.00043734402,0.001048873],"category_scores_gemma":[0.0015288631,0.00020616461,0.0006144857,0.0020920746,0.0002617123,0.000708992,0.0004311993,0.00023643386,0.00021559309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000791416,0.000017560516,0.99395704,0.000104965344,0.000085221545,0.001969025,0.00013246635,0.000025771973,0.0003388289,0.000023922259,0.0002545328,0.0030115135],"study_design_scores_gemma":[0.000004559381,0.00007783982,0.98454434,0.00006241556,0.00011494811,0.013070298,0.00064851646,0.000034739885,0.000106964246,0.00001604244,0.0013112122,0.000008079643],"about_ca_topic_score_codex":0.003242078,"about_ca_topic_score_gemma":0.00340172,"teacher_disagreement_score":0.003242078,"about_ca_system_score_codex":0.00031795498,"about_ca_system_score_gemma":0.00043729504,"threshold_uncertainty_score":0.006446421},"labels":[],"label_agreement":null},{"id":"W2027807531","doi":"10.1007/s12032-009-9388-4","title":"Experience with sorafenib and the elderly patient","year":2009,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Centre for Applied Research in Cancer Control","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Regimen; Adverse effect; Internal medicine; Population; Hematology; Oncology; Quality of life (healthcare); Intensive care medicine; Hepatocellular carcinoma; Nursing","score_opus":0.014705071514812845,"score_gpt":0.2911583709533907,"score_spread":0.2764532994385779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027807531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97554195,0.009493142,0.00042629422,0.0023319144,0.00014603794,0.000016674563,0.00014303735,0.000013139316,0.011887745],"genre_scores_gemma":[0.99038965,0.0059114187,0.00021171127,0.0009208518,0.00027670985,0.000007817948,0.0001688138,0.000008259966,0.002104717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997998,0.00005885764,0.000019546722,0.000020254787,0.000028720178,0.000072830604],"domain_scores_gemma":[0.99950325,0.00010891177,0.00006783155,0.000015878451,0.000029325229,0.0002748585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039287665,0.00026605214,0.00029277097,0.00020724782,0.00092734344,0.0005949008,0.00014397965,0.00050446455,0.0018699764],"category_scores_gemma":[0.00135343,0.0001137173,0.00047266064,0.00040787942,0.00024127649,0.0004802819,0.0004812713,0.00072209485,0.00041374422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047342456,0.0029210795,0.59614927,0.00039521093,0.0005025746,0.17042312,0.0070585418,0.0023678783,0.0063773105,0.003278006,0.016811248,0.1889815],"study_design_scores_gemma":[0.0006427884,0.009896537,0.4091117,0.00027444356,0.0006261853,0.47542387,0.0062007485,0.0019700788,0.0026047325,0.0020994064,0.091014385,0.00013511801],"about_ca_topic_score_codex":0.0013599402,"about_ca_topic_score_gemma":0.0021644547,"teacher_disagreement_score":0.0018699764,"about_ca_system_score_codex":0.00044850472,"about_ca_system_score_gemma":0.000466786,"threshold_uncertainty_score":0.0062556863},"labels":[],"label_agreement":null},{"id":"W2030648013","doi":"10.1007/s12032-011-9935-7","title":"Pericardial effusion and tamponade following interferon alpha treatment for locally advanced melanoma","year":2011,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Pericardial effusion; Cardiac tamponade; Melanoma; Alpha interferon; Cardiotoxicity; Complication; Tamponade; Hematology; Adjuvant; Interferon alfa; Internal medicine; Surgery; Interferon; Chemotherapy; Immunology; Cancer research","score_opus":0.0287976295936739,"score_gpt":0.3101835269169861,"score_spread":0.2813858973233122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030648013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832901,0.005841762,0.0008499692,0.0018881353,0.0002833913,0.00010549351,0.00009545654,0.00006120496,0.0075844405],"genre_scores_gemma":[0.9981846,0.00070586894,0.00012269076,0.00028894554,0.00036039107,0.000011413248,0.000043370957,0.000004431096,0.00027825966],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995421,0.00011624206,0.00006919617,0.000042711305,0.0001031621,0.00012652938],"domain_scores_gemma":[0.9964947,0.001414107,0.0011007381,0.00021805581,0.00015429695,0.0006181015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005616829,0.00066973653,0.0008031027,0.0010190668,0.00081317755,0.0008128726,0.0005179264,0.0020045778,0.0016267542],"category_scores_gemma":[0.0069504734,0.00038718292,0.00073487364,0.0005474793,0.00066529925,0.0010536129,0.000559576,0.002127541,0.00037185007],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016141887,0.0001320842,0.11036799,0.00013771532,0.000087005435,0.87466687,0.00044330454,0.00017110759,0.0025186618,0.00020813438,0.00067055185,0.008982313],"study_design_scores_gemma":[0.0002957912,0.001592931,0.23412834,0.00012216068,0.00022351052,0.75676894,0.0006954578,0.0012219268,0.0020697098,0.00039005207,0.0024543945,0.000036709247],"about_ca_topic_score_codex":0.000958542,"about_ca_topic_score_gemma":0.0015724179,"teacher_disagreement_score":0.0020045778,"about_ca_system_score_codex":0.0009901512,"about_ca_system_score_gemma":0.00058700785,"threshold_uncertainty_score":0.007184088},"labels":[],"label_agreement":null},{"id":"W2054997893","doi":"10.1007/s12032-012-0377-7","title":"Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome","year":2012,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Perioperative; Internal medicine; Hematology; Chemotherapy; Adenocarcinoma; Correlation; Oncology; Outcome (game theory); Anesthesia; Cancer","score_opus":0.03498184436227772,"score_gpt":0.3739299267701498,"score_spread":0.3389480824078721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054997893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99445456,0.0019950953,0.0003917432,0.00036931533,0.000049760405,0.0002168375,0.0003408016,0.000012474447,0.0021693856],"genre_scores_gemma":[0.99726665,0.0005063576,0.0007291754,0.00018187077,0.000032299402,0.00018879112,0.000861697,0.000002743143,0.00023038642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998068,0.000054676213,0.000035113786,0.000030766783,0.000035876965,0.000036694713],"domain_scores_gemma":[0.99953425,0.00008355578,0.00013610396,0.000034276247,0.000059072703,0.00015281448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003164339,0.000108411405,0.00037532643,0.00020943233,0.00026199516,0.00030333555,0.00019187061,0.0001663018,0.0006773611],"category_scores_gemma":[0.0013017333,0.000043692435,0.00033241409,0.0002822003,0.00011535873,0.0001700043,0.0002251485,0.00043114193,0.00009744798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02556972,0.0026762844,0.7588771,0.00038303036,0.0004971787,0.00047713905,0.00023759106,0.0016276896,0.00752117,0.00029460934,0.003553279,0.19828513],"study_design_scores_gemma":[0.00082708366,0.013722707,0.9738549,0.00014294477,0.0005530187,0.0012388319,0.00034378195,0.0012069212,0.002892393,0.0002506669,0.00494548,0.00002138092],"about_ca_topic_score_codex":0.00090842345,"about_ca_topic_score_gemma":0.0024981769,"teacher_disagreement_score":0.00090842345,"about_ca_system_score_codex":0.0006709903,"about_ca_system_score_gemma":0.0010231843,"threshold_uncertainty_score":0.0048683286},"labels":[],"label_agreement":null},{"id":"W2060462961","doi":"10.1007/s12032-011-0098-3","title":"Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer","year":2011,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Sultan Qaboos University","keywords":"Epidermal growth factor receptor; Angiogenesis; Cancer; Medicine; Immunohistochemistry; Cyclooxygenase; Pathology; Internal medicine; Lymph node; Oncology; Biology","score_opus":0.021243309653932962,"score_gpt":0.2752985829510875,"score_spread":0.25405527329715455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060462961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986914,0.0007330758,0.000045610268,0.000045833607,0.000007102148,0.0000020123405,0.00007154647,0.0000030868323,0.0004003865],"genre_scores_gemma":[0.9996834,0.000117833486,0.000034394277,0.0000097767115,0.000014425128,0.0000016262725,0.000059244972,5.4610103e-7,0.000078794554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985814,0.000046950972,0.000014191012,0.000019516867,0.000027383334,0.00003375459],"domain_scores_gemma":[0.9993788,0.00020896705,0.00018648873,0.000034040397,0.000047190875,0.00014449486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003862018,0.00014629005,0.00022760016,0.0005201857,0.0002292952,0.0003536491,0.00019843492,0.00037404624,0.0010793934],"category_scores_gemma":[0.001492543,0.00015599649,0.0002203564,0.000579295,0.00029464514,0.00030448032,0.00024141825,0.00039262223,0.00010608518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032421036,0.000015573007,0.9977907,0.0000070061765,0.00003313199,0.00008875091,0.000013334726,0.00003387043,0.0004921654,0.000013415263,0.000043003623,0.0011447854],"study_design_scores_gemma":[0.000008116385,0.000061338105,0.99903995,0.0000018739946,0.000038756836,0.00030238065,0.00006267005,0.0002683168,0.00009853405,0.0000263829,0.00008977875,0.0000019023043],"about_ca_topic_score_codex":0.0013189185,"about_ca_topic_score_gemma":0.0021161153,"teacher_disagreement_score":0.0013189185,"about_ca_system_score_codex":0.00018383295,"about_ca_system_score_gemma":0.00017822678,"threshold_uncertainty_score":0.003610909},"labels":[],"label_agreement":null},{"id":"W2065261267","doi":"10.1385/mo:21:1:09","title":"Influence of Mesna on the Pharmacokinetics of Cisplatin and Carboplatin in Pediatric Cancer Patients","year":2004,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Health Research Board; Hospital Research Foundation","keywords":"Mesna; Carboplatin; Pharmacokinetics; Cisplatin; Hematology; Medicine; Cancer; Internal medicine; Oncology; Pharmacology; Chemotherapy; Ifosfamide","score_opus":0.009429162759016401,"score_gpt":0.30031027753495865,"score_spread":0.29088111477594225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065261267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979498,0.00090586086,0.00009458494,0.000087018634,0.000008864506,0.0000059757576,0.00008689938,0.000009731067,0.00085120567],"genre_scores_gemma":[0.99935764,0.00017456002,0.000071135764,0.00003272621,0.0000067544593,0.0000039168913,0.00007172453,0.0000052659293,0.00027629457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997472,0.000109015054,0.000017377819,0.000037533442,0.00004611113,0.00004275822],"domain_scores_gemma":[0.99926466,0.00035349143,0.00015801712,0.000031857675,0.00005379606,0.0001380394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025920494,0.00009376583,0.000374373,0.0001281683,0.0001306519,0.0003631143,0.00012427323,0.00016354842,0.0010848953],"category_scores_gemma":[0.0024549705,0.00011130356,0.00016709369,0.00017939176,0.00017995747,0.0003121069,0.000119763936,0.0004281148,0.000119221346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08959902,0.0007246301,0.6340589,0.00013912127,0.0007128228,0.0024417231,0.0008964045,0.0035782086,0.14092787,0.0010866529,0.001657761,0.12417696],"study_design_scores_gemma":[0.0005474638,0.015074413,0.9125799,0.000022960361,0.0005711663,0.0034066306,0.00058414205,0.0026531548,0.05693957,0.00025006224,0.0073408135,0.000029695015],"about_ca_topic_score_codex":0.0014320217,"about_ca_topic_score_gemma":0.0021021552,"teacher_disagreement_score":0.0014320217,"about_ca_system_score_codex":0.00051164767,"about_ca_system_score_gemma":0.00047783498,"threshold_uncertainty_score":0.0037122965},"labels":[],"label_agreement":null},{"id":"W2071857414","doi":"10.1007/s12032-014-0255-6","title":"Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases’ occurrence","year":2014,"lang":"en","type":"article","venue":"Medical Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Research in Immunology and Cancer","funders":"","keywords":"Breast cancer; Single-nucleotide polymorphism; Oncology; Cancer; Internal medicine; Genotyping; Medicine; Genotype; Biology; Metastasis; Cancer research; Gene; Pathology; Genetics","score_opus":0.005094313034997797,"score_gpt":0.29659931643774984,"score_spread":0.29150500340275204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071857414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973314,0.00026420332,0.00087981694,0.00010913105,0.000032861713,0.000007664489,0.00045234038,0.000045912046,0.0008766719],"genre_scores_gemma":[0.9988004,0.00006560482,0.0002979993,0.00003229193,0.000007780143,0.0000036536576,0.00015501353,0.000009797072,0.00062747893],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997882,0.00004515509,0.0000244576,0.00006559384,0.000037895377,0.000038686972],"domain_scores_gemma":[0.9996586,0.00010185275,0.0001242082,0.000030736468,0.000013324685,0.000071363575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001473227,0.00032257548,0.00024248817,0.00066881324,0.00026383507,0.00023094691,0.00024897745,0.00050077314,0.0070117493],"category_scores_gemma":[0.00047944777,0.00021280252,0.00043956147,0.0003514738,0.00027507264,0.00009038652,0.0002258016,0.00047281297,0.00044889378],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051532704,0.00041519618,0.12537861,0.00015804701,0.00049350737,0.028683117,0.00032396812,0.0010848669,0.8216916,0.0014250969,0.0016675423,0.013525358],"study_design_scores_gemma":[0.00014183174,0.00067356904,0.8293845,0.0000500996,0.0006994531,0.06835899,0.00040422755,0.003795064,0.08969456,0.0011845916,0.0055461233,0.000067006025],"about_ca_topic_score_codex":0.0012189721,"about_ca_topic_score_gemma":0.0013800767,"teacher_disagreement_score":0.0070117493,"about_ca_system_score_codex":0.00011960268,"about_ca_system_score_gemma":0.00014760745,"threshold_uncertainty_score":0.023456633},"labels":[],"label_agreement":null},{"id":"W2084749922","doi":"10.1007/s12032-010-9555-7","title":"The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia","year":2010,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hematology; Autocrine signalling; Chronic lymphocytic leukemia; Motility; Cancer research; Internal medicine; Receptor; Leukemia; Immunology; Biology; Medicine; Cell biology","score_opus":0.021566598148324987,"score_gpt":0.329589577789861,"score_spread":0.30802297964153597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084749922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984585,0.00065982545,0.00009366811,0.000036485304,0.0000071542513,0.000003209178,0.00007328175,0.000013467263,0.000654382],"genre_scores_gemma":[0.9992693,0.00017638275,0.000064014486,0.000019517693,0.000009491884,0.0000035890125,0.00011132641,0.0000035438281,0.0003428647],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99988973,0.000018804934,0.0000064807637,0.000011851236,0.000027750762,0.00004535429],"domain_scores_gemma":[0.9998795,0.00002492868,0.000037177328,0.0000090045105,0.000021004791,0.000028454897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000093257026,0.00012188509,0.00017714297,0.0009038364,0.00034171765,0.000513172,0.0001579344,0.000324153,0.0021921291],"category_scores_gemma":[0.0002957746,0.00014142471,0.00010008222,0.00051216735,0.0001960196,0.00022717935,0.00024052038,0.0002649899,0.00033304945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001758301,0.00008461968,0.13513501,0.00010558492,0.00006042999,0.0038833693,0.0002775917,0.00014468447,0.8468945,0.00035093687,0.00092227594,0.010382642],"study_design_scores_gemma":[0.00012824369,0.0003973098,0.8843413,0.000025689447,0.00013617778,0.017807486,0.0014820199,0.0022192562,0.085337326,0.00043009996,0.007671062,0.000024039515],"about_ca_topic_score_codex":0.0021176513,"about_ca_topic_score_gemma":0.0015711668,"teacher_disagreement_score":0.0021921291,"about_ca_system_score_codex":0.0003466787,"about_ca_system_score_gemma":0.00011108472,"threshold_uncertainty_score":0.0073334575},"labels":[],"label_agreement":null},{"id":"W2091449691","doi":"10.1007/s12032-014-0189-z","title":"Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population","year":2014,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba; University of Manitoba","funders":"Zahedan University of Medical Sciences","keywords":"Genotyping; Internal medicine; Single-nucleotide polymorphism; Breast cancer; Allele; Medicine; Genotype; Oncology; Odds ratio; Biology; Gastroenterology; Gynecology; Genetics; Cancer; Gene","score_opus":0.004999736763667266,"score_gpt":0.2571886496494881,"score_spread":0.25218891288582085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091449691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99978715,0.000058639678,0.000022012478,0.000016203825,0.0000017627649,0.0000014381218,0.00002120789,5.234695e-7,0.0000910187],"genre_scores_gemma":[0.99974746,0.00004780527,0.000048612903,0.000015468971,0.0000053270014,0.000002529135,0.000035291472,5.4745743e-7,0.000096833144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998723,0.000033779314,0.000012144003,0.000034057826,0.000021653736,0.000026006497],"domain_scores_gemma":[0.99975413,0.00006340101,0.000082590086,0.000017966428,0.000039263396,0.000042688273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023619526,0.00023524479,0.00019897052,0.0006292825,0.00045395922,0.0002619537,0.00017608725,0.00023994774,0.0010477528],"category_scores_gemma":[0.0006583033,0.00018293942,0.0002539367,0.0006183933,0.00023221695,0.000113055066,0.00011814092,0.0002861188,0.000068782414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001825414,0.00006745464,0.99608934,0.0000072460143,0.00005745651,0.0002375409,0.00027057587,0.00002772375,0.0016691945,0.00003782769,0.000055803008,0.0012973599],"study_design_scores_gemma":[0.0000078706935,0.000089331996,0.9988066,0.0000021706257,0.00004173583,0.00041500866,0.00025962296,0.00012680492,0.00010972138,0.000027238666,0.000111988884,0.000001883259],"about_ca_topic_score_codex":0.0084350435,"about_ca_topic_score_gemma":0.00836368,"teacher_disagreement_score":0.0084350435,"about_ca_system_score_codex":0.00020417667,"about_ca_system_score_gemma":0.00027985882,"threshold_uncertainty_score":0.016771913},"labels":[],"label_agreement":null},{"id":"W2119967200","doi":"10.1007/s12032-011-0016-8","title":"Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement","year":2011,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Novartis Pharma; Sanofi; Bayer HealthCare; GlaxoSmithKline; Pfizer","keywords":"Sunitinib; Sorafenib; Temsirolimus; Everolimus; Medicine; Pazopanib; Renal cell carcinoma; Bevacizumab; Internal medicine; Oncology; Axitinib; Pharmacology; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway; Chemotherapy; Biology","score_opus":0.07924066159462474,"score_gpt":0.3525873089175282,"score_spread":0.2733466473229035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119967200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019206307,0.99796045,0.00023676353,0.00068052125,0.00018320409,0.000011804705,0.000025658816,0.000003090692,0.0007065208],"genre_scores_gemma":[0.002368614,0.9953322,0.0006814689,0.0007840148,0.00022155052,0.000023824854,0.000044158955,0.0000022901247,0.00054187793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995647,0.00010099081,0.00009828409,0.00006961043,0.00013229229,0.000034100867],"domain_scores_gemma":[0.9989773,0.0006705824,0.00014135934,0.00002000925,0.00016748827,0.000023330043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020284585,0.0006708276,0.0023625449,0.0009514119,0.00017717962,0.0011803905,0.0013012593,0.0016391714,0.002167632],"category_scores_gemma":[0.0014773295,0.00032994253,0.0012567132,0.0011846094,0.00045662854,0.0014142873,0.0005012192,0.0020346146,0.00079739676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002528372,0.00008651023,0.00017020771,0.029481895,0.0003398758,0.00013851507,0.000054484935,0.0008560251,0.0015968139,0.003998863,0.015954295,0.94706964],"study_design_scores_gemma":[0.0002668919,0.0004430964,0.0017272186,0.024143524,0.0012172661,0.0012544232,0.00010330619,0.0004685863,0.0016097184,0.0043078708,0.964405,0.00005306025],"about_ca_topic_score_codex":0.0013621547,"about_ca_topic_score_gemma":0.002849666,"teacher_disagreement_score":0.0023625449,"about_ca_system_score_codex":0.0008809784,"about_ca_system_score_gemma":0.0013340572,"threshold_uncertainty_score":0.010727704},"labels":[],"label_agreement":null},{"id":"W2266378286","doi":"10.1007/s12032-015-0682-z","title":"Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia","year":2015,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Moncton Hospital","funders":"Amgen","keywords":"Medicine; Febrile neutropenia; Internal medicine; Chemotherapy; Granulocyte colony-stimulating factor; Neutropenia; Hematology; Risk factor; Observational study; Incidence (geometry); Risk assessment","score_opus":0.03188136543637082,"score_gpt":0.34012430570433116,"score_spread":0.30824294026796034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266378286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946972,0.00019250017,0.00007634378,0.0025762354,0.00005542942,0.000016058295,0.00001912286,0.00000257342,0.0023645624],"genre_scores_gemma":[0.9978885,0.00017627799,0.00013148018,0.0014761158,0.000046528643,0.0000072475855,0.000014564169,0.000001612847,0.00025768232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755234,0.0012237702,0.00019205724,0.000112871785,0.0005053471,0.00041354008],"domain_scores_gemma":[0.97669137,0.010252259,0.006534004,0.00029210155,0.0018958307,0.004334425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033399358,0.000143257,0.00023999672,0.0006615868,0.001517143,0.0013328367,0.0002877056,0.0011504847,0.002535156],"category_scores_gemma":[0.02797443,0.0002529788,0.0004078872,0.0004132507,0.0011897134,0.0007003353,0.0006257187,0.0015371616,0.00023115025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033964193,0.0004836792,0.9813421,0.00003779966,0.000057554764,0.00040791,0.00839163,0.0001435305,0.00043356995,0.00018022617,0.0009245492,0.007258015],"study_design_scores_gemma":[0.00010194533,0.0014604061,0.9410904,0.00022237026,0.00010332247,0.0014085989,0.048759457,0.0011521074,0.00039069017,0.00031971856,0.004932999,0.000057942736],"about_ca_topic_score_codex":0.010714157,"about_ca_topic_score_gemma":0.013485705,"teacher_disagreement_score":0.010714157,"about_ca_system_score_codex":0.001274217,"about_ca_system_score_gemma":0.0018967062,"threshold_uncertainty_score":0.021303535},"labels":[],"label_agreement":null},{"id":"W2397942762","doi":"10.1007/s12032-016-0774-4","title":"A pilot trial of FLOT neoadjuvant chemotherapy for resectable esophagogastric junction adenocarcinoma","year":2016,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Docetaxel; Medicine; Oxaliplatin; Internal medicine; Oncology; Chemotherapy; Adenocarcinoma; Dysphagia; Fluorouracil; Neoadjuvant therapy; Gastroenterology; Surgery; Cancer; Colorectal cancer","score_opus":0.042065308387924,"score_gpt":0.34012841807471694,"score_spread":0.29806310968679295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397942762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961583,0.0007713075,0.00018974072,0.00067749503,0.00027211913,0.00071837497,0.0002687586,0.000027365442,0.0009164654],"genre_scores_gemma":[0.9946759,0.0006842956,0.0006858764,0.00059981755,0.00027638025,0.0012429754,0.00067304506,0.000016422458,0.0011453212],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995053,0.00024701896,0.000031737785,0.00009090605,0.000021663982,0.00010346126],"domain_scores_gemma":[0.99885464,0.00031812806,0.00015474102,0.00011028362,0.000056526576,0.0005056315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011878846,0.0010111189,0.0020552697,0.00030616252,0.0005145329,0.0008291984,0.0006413409,0.0012138261,0.004863742],"category_scores_gemma":[0.0015904594,0.0003789183,0.0017749607,0.00034813414,0.0015680419,0.0011878104,0.00050054764,0.0030729335,0.00074048765],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95603603,0.018153993,0.0019106872,0.000304803,0.0007134078,0.00012614908,0.0000934948,0.0006393311,0.004675875,0.0001578627,0.0008016073,0.016386766],"study_design_scores_gemma":[0.4963329,0.4946766,0.0057258736,0.000037623064,0.00057881494,0.00009800407,0.00009151648,0.00048848905,0.00082276587,0.00016408353,0.00096259854,0.000020699348],"about_ca_topic_score_codex":0.00085472385,"about_ca_topic_score_gemma":0.002079771,"teacher_disagreement_score":0.004863742,"about_ca_system_score_codex":0.0008072001,"about_ca_system_score_gemma":0.0011144833,"threshold_uncertainty_score":0.016270816},"labels":[],"label_agreement":null},{"id":"W2414935720","doi":"10.1007/s12032-016-0784-2","title":"ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women","year":2016,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"ABO blood group system; Medicine; Breast cancer; Internal medicine; Breast carcinoma; Oncology; Incidence (geometry); Hematology; Estrogen receptor; Blood type (non-human); Carcinoma; Cancer; Gynecology","score_opus":0.00969696580763495,"score_gpt":0.26070885696520335,"score_spread":0.2510118911575684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414935720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898976,0.00045314914,0.000015833935,0.00007446003,0.00000851159,0.0000016984667,0.00009736225,0.0000014093063,0.00035787048],"genre_scores_gemma":[0.9995029,0.00018403771,0.000018982782,0.000021839298,0.000015586036,0.0000024284407,0.000068597335,9.259991e-7,0.00018472454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998134,0.00004910215,0.000014979638,0.000025618914,0.00001909269,0.0000777962],"domain_scores_gemma":[0.999421,0.00013899899,0.00024193655,0.000027441669,0.000049935,0.00012065092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027597076,0.00022499397,0.00022138958,0.0007694862,0.0004806125,0.0004929932,0.00029652988,0.00034255083,0.0017887605],"category_scores_gemma":[0.0012783988,0.0002240589,0.0003406649,0.0011341873,0.00027517363,0.00024651474,0.00035164104,0.0004538186,0.00019639338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028178724,0.000033141077,0.9977969,0.000008678699,0.000043728243,0.00017050904,0.00015975948,0.000029009248,0.00024045949,0.00003142945,0.000075569325,0.0011291372],"study_design_scores_gemma":[0.0000058681285,0.00007257358,0.99871624,0.000008630379,0.000041147407,0.00018077806,0.0005336731,0.00015594525,0.000047281763,0.000034552413,0.00019991309,0.0000034162322],"about_ca_topic_score_codex":0.01425622,"about_ca_topic_score_gemma":0.011989759,"teacher_disagreement_score":0.01425622,"about_ca_system_score_codex":0.0005091711,"about_ca_system_score_gemma":0.00039821726,"threshold_uncertainty_score":0.028346479},"labels":[],"label_agreement":null},{"id":"W2608513919","doi":"10.1007/s12032-017-0968-4","title":"Need for new review of article on ketogenic dietary regimes for cancer patients","year":2017,"lang":"en","type":"letter","venue":"Medical Oncology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hematology; Medicine; Ketogenic diet; Cancer; Internal medicine; Oncology; Psychiatry","score_opus":0.06330595158205803,"score_gpt":0.39093751486010847,"score_spread":0.32763156327805043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608513919","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036141614,0.14144453,0.00027728567,0.69274145,0.15830293,0.0000351611,0.00015963765,0.000043688644,0.0066338284],"genre_scores_gemma":[0.0023686988,0.083515406,0.0007098084,0.5551229,0.35326827,0.00009006477,0.00014195188,0.000032768025,0.0047501647],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997835,0.0008014873,0.0005203598,0.0001892626,0.00052345014,0.00013031694],"domain_scores_gemma":[0.9738253,0.016462773,0.0020376542,0.00061052456,0.005624276,0.0014394213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027689885,0.0005279548,0.0017474723,0.0015645816,0.0012252511,0.0030900193,0.0010016474,0.009298251,0.009985446],"category_scores_gemma":[0.02506393,0.00027685307,0.00097147754,0.0011643798,0.0017160837,0.0033137233,0.0010658868,0.011262993,0.0041331025],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007177513,0.000033026496,0.00038837938,0.0016011249,0.0000345065,0.0009242127,0.00005382973,0.000024617962,0.000108675704,0.001135856,0.9397793,0.05584469],"study_design_scores_gemma":[0.00012807958,0.000044038403,0.00068814965,0.0043839742,0.0001112311,0.002546875,0.00023653003,0.000048727245,0.00008319463,0.0039685494,0.9877367,0.000023872833],"about_ca_topic_score_codex":0.00094324624,"about_ca_topic_score_gemma":0.0028465388,"teacher_disagreement_score":0.009985446,"about_ca_system_score_codex":0.0022360203,"about_ca_system_score_gemma":0.0037856968,"threshold_uncertainty_score":0.03340465},"labels":[],"label_agreement":null},{"id":"W2744689594","doi":"10.1007/s12032-017-1018-y","title":"Incidence and identification of risk factors for trastuzumab-induced cardiotoxicity in breast cancer patients: an audit of a single “real-world” setting","year":2017,"lang":"en","type":"article","venue":"Medical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Genentech","keywords":"Trastuzumab; Medicine; Internal medicine; Breast cancer; Anthracycline; Oncology; Cardiotoxicity; Incidence (geometry); Population; Ejection fraction; Cancer; Surgery; Chemotherapy; Heart failure","score_opus":0.054160820954944164,"score_gpt":0.42862162170200696,"score_spread":0.3744608007470628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744689594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972101,0.0005587158,0.00027891024,0.00006399366,0.0000063862553,0.00005645364,0.0009944141,0.000016512133,0.0008144992],"genre_scores_gemma":[0.998648,0.00025973129,0.00022649436,0.000050449165,0.0000092508135,0.000021755868,0.0007088004,0.000006797504,0.000068834546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971027,0.0009557425,0.0005623669,0.00053998036,0.0005292459,0.0003099711],"domain_scores_gemma":[0.99257845,0.0013237584,0.0034282606,0.00069540157,0.0012914187,0.0006828201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017454437,0.00026977685,0.0005416008,0.0015895994,0.00044093272,0.0009008805,0.0004865862,0.00053057173,0.00070960075],"category_scores_gemma":[0.005183734,0.00033352192,0.00063724717,0.0015117134,0.00055185315,0.00067642285,0.0009297392,0.0004740802,0.00019511374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023797479,0.000053228036,0.995899,0.000041513533,0.00005953332,0.00026633238,0.00010936692,0.00009920474,0.00030566333,0.000018082384,0.00017635993,0.0027335647],"study_design_scores_gemma":[0.000019336037,0.0004963171,0.9962025,0.000021737831,0.000066696186,0.0016516512,0.00034337136,0.00023387025,0.00044983128,0.000017218208,0.0004862055,0.000011318165],"about_ca_topic_score_codex":0.0035625244,"about_ca_topic_score_gemma":0.004354645,"teacher_disagreement_score":0.0035625244,"about_ca_system_score_codex":0.0008659204,"about_ca_system_score_gemma":0.0010552533,"threshold_uncertainty_score":0.009230912},"labels":[],"label_agreement":null},{"id":"W2771113036","doi":"10.1007/s12032-017-1068-1","title":"Large-scale DNA organization is a prognostic marker of breast cancer survival","year":2017,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Occupational Cancer Research Centre; BC Cancer Agency","funders":"","keywords":"Hematology; Breast cancer; Internal medicine; Oncology; Cancer; Scale (ratio); Medicine; Biology; Geography; Cartography","score_opus":0.010390571954186837,"score_gpt":0.2957970185228316,"score_spread":0.2854064465686447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771113036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651897,0.0010204002,0.0009430726,0.000108997854,0.000011329245,0.0000045509382,0.0005338622,0.000023760722,0.0008350998],"genre_scores_gemma":[0.9989033,0.00016012159,0.00020442827,0.000016802898,0.000015598702,0.0000033573347,0.00037662883,0.000004933649,0.00031482056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999808,0.000047695772,0.000014861907,0.00005625405,0.000036710433,0.000036466394],"domain_scores_gemma":[0.99818146,0.0004361862,0.0009369773,0.00012940889,0.00012492256,0.00019110189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022963258,0.00017224508,0.00022473521,0.00093137054,0.0002291326,0.0005124359,0.00017783616,0.00028309037,0.0021720126],"category_scores_gemma":[0.0012603627,0.00012135324,0.0001615914,0.0010066556,0.00027980414,0.0003668958,0.00035221592,0.00031038967,0.00061767764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007903271,0.00006528165,0.9171752,0.000044858312,0.00015081535,0.00017502496,0.00013076064,0.0004843915,0.06918104,0.00022913972,0.00032697176,0.011246169],"study_design_scores_gemma":[0.000009454712,0.00017693375,0.98979014,0.000006985703,0.000055658747,0.0005435241,0.00018513943,0.00083309616,0.0066479277,0.00061011035,0.0011326076,0.000008472248],"about_ca_topic_score_codex":0.0004753753,"about_ca_topic_score_gemma":0.00047876273,"teacher_disagreement_score":0.0021720126,"about_ca_system_score_codex":0.00014655784,"about_ca_system_score_gemma":0.000120393255,"threshold_uncertainty_score":0.007266164},"labels":[],"label_agreement":null},{"id":"W2798125119","doi":"10.1007/s12032-018-1129-0","title":"Impact of smoking history on the outcomes of women with early-stage breast cancer: a secondary analysis of a randomized study","year":2018,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Randomized controlled trial; Hematology; Internal medicine; Oncology; Stage (stratigraphy); Cancer; Gynecology; Biology","score_opus":0.02103808565928163,"score_gpt":0.3534355698312613,"score_spread":0.3323974841719797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2798125119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947408,0.0024973527,0.00061970646,0.0001602263,0.00021194736,0.00070036517,0.00057895604,0.00001999366,0.00047080955],"genre_scores_gemma":[0.9965668,0.0006858848,0.0006475439,0.00025080287,0.00031093459,0.0004619158,0.0005853529,0.000011205697,0.00047955688],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9902417,0.006973488,0.00061723404,0.0009848023,0.0005830133,0.0005996963],"domain_scores_gemma":[0.9863149,0.007673768,0.0023583022,0.001977064,0.0007136566,0.0009623038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008711849,0.0017759529,0.004100714,0.00055414333,0.00076570624,0.0014797645,0.0012326327,0.0020873058,0.003516551],"category_scores_gemma":[0.013087847,0.0009532283,0.00768022,0.00076215115,0.0014588166,0.0011311333,0.00096551067,0.0027306357,0.00036906012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94101727,0.006739168,0.022091169,0.0008895583,0.020539222,0.000100484474,0.00007349218,0.0004049378,0.0013202869,0.00012676325,0.00034702918,0.006350621],"study_design_scores_gemma":[0.67230123,0.15640578,0.10075457,0.0002084022,0.06417072,0.00019448817,0.00018933967,0.002102654,0.0017385508,0.00071490323,0.0011055472,0.0001138164],"about_ca_topic_score_codex":0.0019696353,"about_ca_topic_score_gemma":0.0028353164,"teacher_disagreement_score":0.008711849,"about_ca_system_score_codex":0.00096801843,"about_ca_system_score_gemma":0.0016018708,"threshold_uncertainty_score":0.0460732},"labels":[],"label_agreement":null},{"id":"W2809614382","doi":"10.1007/s12032-018-1167-7","title":"Generalizability of clinical trials of advanced melanoma in the real-world, population-based setting","year":2018,"lang":"en","type":"article","venue":"Medical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baker Hughes (Canada); Occupational Cancer Research Centre; University of Calgary","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Medicine; Ipilimumab; Clinical trial; Cohort; Internal medicine; Population; Vemurafenib; Cancer; Oncology; Metastatic melanoma; Immunotherapy","score_opus":0.17206039468019826,"score_gpt":0.5487670947428749,"score_spread":0.3767067000626766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809614382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5101606,0.14487268,0.09837159,0.048300385,0.017544348,0.031274736,0.032708257,0.0016289033,0.11513845],"genre_scores_gemma":[0.9605175,0.0040230365,0.007792748,0.013909774,0.001771111,0.006575627,0.0032805062,0.00022083799,0.001908852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6154156,0.30542874,0.03941398,0.022761019,0.014668635,0.0023120784],"domain_scores_gemma":[0.44859356,0.40850657,0.042026293,0.07906803,0.018051274,0.0037543366],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.27634552,0.001741821,0.0044517596,0.0026229525,0.0016301995,0.005685856,0.0031561193,0.0036222828,0.014097545],"category_scores_gemma":[0.5082989,0.001032653,0.0075992863,0.0034922946,0.0045681777,0.0043643913,0.0032029382,0.0040512276,0.0018525822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06305824,0.002477617,0.48352563,0.024651561,0.103537634,0.0015677146,0.0042327326,0.010317512,0.0035600378,0.011933498,0.048038136,0.24309967],"study_design_scores_gemma":[0.05375594,0.032273326,0.6341776,0.00912403,0.067587405,0.0028866772,0.0039235773,0.012222566,0.0043558665,0.047209322,0.13208161,0.00040209087],"about_ca_topic_score_codex":0.003677223,"about_ca_topic_score_gemma":0.0038468556,"teacher_disagreement_score":0.27634552,"about_ca_system_score_codex":0.003083638,"about_ca_system_score_gemma":0.003094535,"threshold_uncertainty_score":0.8923948},"labels":[],"label_agreement":null},{"id":"W2809759086","doi":"10.1007/s12032-018-1176-6","title":"Eligibility of real-world patients with chemo-refractory, K-RAS wild-type, metastatic colorectal cancer for palliative intent regorafenib monotherapy","year":2018,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services; University of British Columbia","funders":"Mach-Gaensslen Foundation of Canada","keywords":"Regorafenib; Medicine; Panitumumab; Cetuximab; Internal medicine; Colorectal cancer; Oncology; Refractory (planetary science); Hazard ratio; Cancer; Confidence interval","score_opus":0.03908954373305832,"score_gpt":0.4008448936769791,"score_spread":0.3617553499439208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809759086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98651254,0.0012229776,0.00064007926,0.0007717653,0.00005465524,0.00071966014,0.005286091,0.00001144162,0.004780696],"genre_scores_gemma":[0.99256456,0.00047546544,0.0007986995,0.00066971616,0.000053162963,0.00061892095,0.004028419,0.000007927367,0.00078318553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954826,0.00019054444,0.00007524319,0.000078311605,0.000045846427,0.00006180087],"domain_scores_gemma":[0.9991304,0.00024312752,0.00032564416,0.00006114367,0.00010615662,0.00013353668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072160264,0.00017834101,0.00036134606,0.00037476758,0.00059190125,0.0006608262,0.00024359814,0.0003802532,0.0060022753],"category_scores_gemma":[0.0034244088,0.00010228259,0.00035150629,0.00055469375,0.0002929276,0.00032006018,0.00034261486,0.0002358885,0.0008218842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008899109,0.0008059385,0.92658067,0.0010105215,0.00029214754,0.003947815,0.0011813788,0.00081654754,0.0030113985,0.0013181126,0.015361098,0.036775302],"study_design_scores_gemma":[0.0013606878,0.0031229125,0.93206686,0.0005402149,0.0004730361,0.008818805,0.004796326,0.002158462,0.0011979467,0.0014463024,0.043937545,0.00008100739],"about_ca_topic_score_codex":0.0022534207,"about_ca_topic_score_gemma":0.004236145,"teacher_disagreement_score":0.0060022753,"about_ca_system_score_codex":0.00035604805,"about_ca_system_score_gemma":0.0007235707,"threshold_uncertainty_score":0.020079613},"labels":[],"label_agreement":null},{"id":"W2811271130","doi":"10.1007/s12032-018-1173-9","title":"A population-based analysis of urban–rural disparities in advanced pancreatic cancer management and outcomes","year":2018,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency; Faculty of Medicine, University of British Columbia; University of Calgary","keywords":"Medicine; Rurality; Gemcitabine; FOLFIRINOX; Pancreatic cancer; Internal medicine; Population; Cancer; Cancer registry; Residence; Rural area; Oncology; Emergency medicine; Demography; Environmental health; Colorectal cancer; Irinotecan; Pathology","score_opus":0.02199292592659263,"score_gpt":0.3957228298689264,"score_spread":0.37372990394233374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811271130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988809,0.000084503496,0.00009183158,0.000085034226,0.000005413861,0.000007634113,0.00048156062,0.000002422247,0.00036081846],"genre_scores_gemma":[0.99939156,0.00003616678,0.000056680343,0.000047764057,0.000007729583,0.000010819954,0.00033499065,0.0000019210695,0.0001123032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990331,0.0003696029,0.000083218765,0.00020562476,0.000098576034,0.00020978395],"domain_scores_gemma":[0.99871325,0.00024056535,0.00049415557,0.00013772503,0.00014442162,0.00026990904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008213361,0.00024964276,0.0003187617,0.0009408689,0.00081816665,0.00070879346,0.00051906484,0.0005910058,0.0022364492],"category_scores_gemma":[0.0022480215,0.0003065647,0.0008864453,0.0023761424,0.0004119602,0.0008618811,0.0011523888,0.00077231077,0.0002823801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022548628,0.00014558919,0.99703753,0.000015230452,0.00020084718,0.00005148613,0.00028672357,0.00004634223,0.0001818784,0.00008361512,0.0002932513,0.0014321324],"study_design_scores_gemma":[0.000017154889,0.00013415674,0.99822325,0.0000054958687,0.00007155612,0.00008011544,0.0008970853,0.00016346059,0.000030965,0.00006190293,0.00030938126,0.000005380664],"about_ca_topic_score_codex":0.017449237,"about_ca_topic_score_gemma":0.022620415,"teacher_disagreement_score":0.017449237,"about_ca_system_score_codex":0.00057960313,"about_ca_system_score_gemma":0.0006866444,"threshold_uncertainty_score":0.034695327},"labels":[],"label_agreement":null},{"id":"W2885584381","doi":"10.1007/s12032-018-1189-1","title":"Improved survival with higher doses of octreotide long-acting release in gastroenteropancreatic neuroendocrine tumors","year":2018,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Octreotide; Hematology; Neuroendocrine tumors; Medicine; Internal medicine; Oncology; Somatostatin","score_opus":0.02250499720702019,"score_gpt":0.34523809930641824,"score_spread":0.32273310209939804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885584381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947931,0.0033356317,0.00036467097,0.00018371387,0.0000415755,0.000009553395,0.0000722783,0.000018455281,0.0011808891],"genre_scores_gemma":[0.9979412,0.0009008834,0.0003684513,0.00012691735,0.000025419613,0.000007545677,0.00019126137,0.00000846891,0.00042983438],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999231,0.000024280384,0.0000058250025,0.000013106106,0.0000138606265,0.000019884104],"domain_scores_gemma":[0.99988174,0.000050981653,0.000017783785,0.000015801425,0.000008272783,0.000025488602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024154442,0.000104157996,0.00028983847,0.000088547706,0.00008251109,0.00022595258,0.000117559255,0.00017342437,0.0012728458],"category_scores_gemma":[0.00028166914,0.00004012204,0.00038132572,0.00012391103,0.00010644673,0.00024938132,0.000099637626,0.00039224327,0.000118684155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057243265,0.0028633,0.09467794,0.00051830657,0.0009439951,0.0017494891,0.00023057881,0.0070325285,0.30457842,0.00066412776,0.0022909197,0.52720714],"study_design_scores_gemma":[0.004256458,0.091870256,0.7489153,0.00014537842,0.0016768122,0.007348975,0.0003353706,0.007274796,0.114999205,0.0011449282,0.02194871,0.000083798564],"about_ca_topic_score_codex":0.00040341384,"about_ca_topic_score_gemma":0.0011059659,"teacher_disagreement_score":0.0012728458,"about_ca_system_score_codex":0.0002671194,"about_ca_system_score_gemma":0.00017878744,"threshold_uncertainty_score":0.004258156},"labels":[],"label_agreement":null},{"id":"W2887050785","doi":"10.1007/s12032-018-1182-8","title":"Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer","year":2018,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Proportional hazards model; Stage (stratigraphy); Lung cancer; Oncology; Survival analysis; Cancer; Retrospective cohort study; Metastasis; Overall survival; Gastroenterology","score_opus":0.03098294841377625,"score_gpt":0.4058160447346547,"score_spread":0.37483309632087847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887050785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584794,0.0019858312,0.00011652159,0.00034111802,0.0000477069,0.000004665911,0.00018682511,0.000005051494,0.0014643592],"genre_scores_gemma":[0.9990853,0.00020013217,0.000038141035,0.00004704914,0.000047837068,0.0000018705692,0.00012458314,0.0000040139103,0.0004510265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946755,0.00024472392,0.000038554732,0.000072036804,0.00005979874,0.00011732537],"domain_scores_gemma":[0.9978666,0.0010742146,0.00043061213,0.000072194016,0.000087975015,0.00046843066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091564475,0.00024557498,0.00033947115,0.00028760414,0.00025545343,0.00064597087,0.0003376276,0.0005855201,0.0041061994],"category_scores_gemma":[0.0037770206,0.00012387535,0.0010018077,0.0003059218,0.0004155617,0.00067483465,0.00057257793,0.0005730614,0.0002966314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008622985,0.00018096204,0.95901406,0.00009708404,0.00042438833,0.00035570524,0.00009282547,0.001389976,0.0022000144,0.00011631168,0.00053642265,0.026969323],"study_design_scores_gemma":[0.000067680776,0.001726254,0.9945747,0.00002956833,0.0004333751,0.00042995007,0.00033032303,0.0013059516,0.00030244148,0.00023982266,0.0005490572,0.000010848512],"about_ca_topic_score_codex":0.0020420554,"about_ca_topic_score_gemma":0.0064477846,"teacher_disagreement_score":0.0041061994,"about_ca_system_score_codex":0.0004023216,"about_ca_system_score_gemma":0.00033386104,"threshold_uncertainty_score":0.013736606},"labels":[],"label_agreement":null},{"id":"W2887520055","doi":"10.1007/s12032-018-1186-4","title":"Broccoli extract improves chemotherapeutic drug efficacy against head–neck squamous cell carcinomas","year":2018,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Genomics, phytochemicals, and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Ministry of Higher Education, Egypt","keywords":"Sulforaphane; Cisplatin; Apoptosis; Viability assay; Cancer research; Cytotoxicity; Cell; Cancer; Pharmacology; Cell culture; Cancer cell; Medicine; Chemistry; Chemotherapy; Biology; Internal medicine; In vitro; Biochemistry","score_opus":0.01284003207491781,"score_gpt":0.2908046985930688,"score_spread":0.277964666518151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887520055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962632,0.0022872447,0.00020000832,0.00013710484,0.000026721158,0.000022872238,0.00013218721,0.000036324906,0.0008942985],"genre_scores_gemma":[0.9963186,0.0017353098,0.0002703062,0.00006865762,0.000014484896,0.000008685134,0.0002459326,0.000007966978,0.0013299526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99995637,0.000010725246,0.0000032134126,0.0000071747413,0.000009110815,0.000013462651],"domain_scores_gemma":[0.9999504,0.000009613451,0.000012214284,0.0000061136775,0.000009228051,0.0000125503875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009841234,0.0002056818,0.00034024587,0.0003297215,0.00015459243,0.00015774416,0.00015341793,0.00018283671,0.0022142015],"category_scores_gemma":[0.0001055381,0.00008799057,0.00019156148,0.00016428897,0.00012930861,0.00014695051,0.00008634414,0.0004370802,0.00023900728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032339476,0.0005736796,0.0007170472,0.000117666736,0.000045171935,0.0000427515,0.000025387271,0.00007066123,0.98048806,0.000043655855,0.00019229122,0.014449715],"study_design_scores_gemma":[0.0008362385,0.014311471,0.07897207,0.000058884245,0.0006033088,0.0003842966,0.00014536761,0.00076925056,0.8953893,0.00011717143,0.008391633,0.000021019905],"about_ca_topic_score_codex":0.0013881022,"about_ca_topic_score_gemma":0.0025114696,"teacher_disagreement_score":0.0022142015,"about_ca_system_score_codex":0.00011639263,"about_ca_system_score_gemma":0.00016105286,"threshold_uncertainty_score":0.0074071884},"labels":[],"label_agreement":null},{"id":"W2887957299","doi":"10.1007/s12032-018-1188-2","title":"Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients","year":2018,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Calgary; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; FOLFOX; Anemia; Capecitabine; Colorectal cancer; Gastroenterology; Cancer; Chemotherapy; Univariate analysis; Oncology; Toxicity; Multivariate analysis; Oxaliplatin","score_opus":0.009140483195439038,"score_gpt":0.29692924581178587,"score_spread":0.28778876261634684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887957299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981816,0.00070937996,0.000054993645,0.00006136599,0.000007247889,0.0000040389505,0.0005028646,0.000001956599,0.00047652668],"genre_scores_gemma":[0.9992594,0.00013280773,0.00002991817,0.000030497664,0.000008993452,0.000003966824,0.00038492706,0.0000013416438,0.00014822587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972993,0.00007081321,0.000046490462,0.000044336855,0.000036898993,0.000071431794],"domain_scores_gemma":[0.99858356,0.00051565253,0.00058780884,0.00007122262,0.000068843496,0.00017301609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003034148,0.00009396705,0.0002500518,0.000280351,0.00016522448,0.00037539835,0.000121498786,0.00025085005,0.0018830703],"category_scores_gemma":[0.00230145,0.00009959821,0.0005177053,0.0007523427,0.000116274925,0.00029262115,0.00017224425,0.0004902201,0.0000958065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007928789,0.000037271882,0.99669254,0.00001676058,0.00012794622,0.00005757256,0.000017484215,0.00007744694,0.00025912805,0.00002251175,0.00010494171,0.0017935219],"study_design_scores_gemma":[0.000019000081,0.00018278466,0.9990332,0.0000061267265,0.00006524458,0.00014525162,0.00005879647,0.00014584638,0.000073190626,0.00003314406,0.00023455312,0.0000029365142],"about_ca_topic_score_codex":0.0019935493,"about_ca_topic_score_gemma":0.003526626,"teacher_disagreement_score":0.0019935493,"about_ca_system_score_codex":0.00030175,"about_ca_system_score_gemma":0.0004045839,"threshold_uncertainty_score":0.006299436},"labels":[],"label_agreement":null},{"id":"W2903160382","doi":"10.1007/s12032-018-1224-2","title":"HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient’s care behalf the CANCERVIH Group","year":2018,"lang":"en","type":"letter","venue":"Medical Oncology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Agence Nationale de la Recherche","keywords":"Multidisciplinary approach; Life expectancy; Medicine; Population; Family medicine; Human immunodeficiency virus (HIV); Cancer; Health care; Internal medicine; Environmental health; Political science","score_opus":0.010984173124076235,"score_gpt":0.2897917215406334,"score_spread":0.27880754841655714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903160382","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093604607,0.0009381318,0.00007398288,0.98597175,0.007925882,0.0000064525175,0.000007969893,0.000010419353,0.0041293986],"genre_scores_gemma":[0.018488765,0.0016117415,0.0005002098,0.94388795,0.02550323,0.000033924913,0.000015774669,0.000027422111,0.009930845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967843,0.0012895903,0.00025232724,0.00034496447,0.0006286536,0.0007000146],"domain_scores_gemma":[0.99083614,0.0025655774,0.0005008304,0.00029631608,0.0012575131,0.004543721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025180983,0.0004383497,0.0005972246,0.00040622617,0.0068178014,0.00412306,0.001311082,0.03251158,0.011434126],"category_scores_gemma":[0.016641863,0.0005572548,0.00062495406,0.00033240995,0.0030722236,0.004387966,0.00271855,0.032667138,0.0026320557],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022426706,0.000077432924,0.0035534208,0.000036391204,0.000017228605,0.0071220053,0.0005234949,0.00008444135,0.00024751446,0.0048079547,0.96970147,0.013806163],"study_design_scores_gemma":[0.00007560301,0.00006954078,0.0025871398,0.0005412049,0.000021289188,0.010339331,0.0032737136,0.00045120972,0.00021806803,0.01134984,0.9710084,0.000064636966],"about_ca_topic_score_codex":0.0044705737,"about_ca_topic_score_gemma":0.013450745,"teacher_disagreement_score":0.03251158,"about_ca_system_score_codex":0.0038899158,"about_ca_system_score_gemma":0.007339199,"threshold_uncertainty_score":0.038250983},"labels":[],"label_agreement":null},{"id":"W2913228817","doi":"10.1007/s12032-018-1238-9","title":"The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity","year":2019,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Docetaxel; Medicine; Discontinuation; Toxicity; Chemotherapy; Prostate cancer; Internal medicine; Oncology; Cancer; Urology","score_opus":0.042340011160148246,"score_gpt":0.38235724981843144,"score_spread":0.3400172386582832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913228817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373437,0.011803579,0.0011712504,0.00015560891,0.000079680874,0.00004094757,0.00029293212,0.000033917502,0.0026877513],"genre_scores_gemma":[0.99816316,0.0009362568,0.00025762254,0.000054949378,0.00003587456,0.000007949276,0.00015019998,0.000014167955,0.00037991282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992644,0.00027009868,0.000101875725,0.00009348151,0.00018210063,0.00008799104],"domain_scores_gemma":[0.99382246,0.0028226494,0.0022711025,0.00022837243,0.00029251538,0.00056288025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012049214,0.00018441967,0.00047421266,0.00046700943,0.00021817692,0.0006978166,0.00027093547,0.00034250153,0.001205859],"category_scores_gemma":[0.008880584,0.00023678603,0.00053162215,0.00055548764,0.00016945341,0.00039375346,0.0001718987,0.0006837747,0.00019270447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019146867,0.0005415873,0.8873482,0.0002214129,0.0004815494,0.0012755615,0.00016444348,0.0029794592,0.016146844,0.0004609335,0.0008626236,0.070370466],"study_design_scores_gemma":[0.0001768673,0.007096525,0.97362375,0.00010786017,0.0005978649,0.0048311,0.00015992868,0.0022671875,0.007317479,0.00036127993,0.0034238016,0.000036404148],"about_ca_topic_score_codex":0.0011390158,"about_ca_topic_score_gemma":0.0019980615,"teacher_disagreement_score":0.001205859,"about_ca_system_score_codex":0.00076130475,"about_ca_system_score_gemma":0.00063851377,"threshold_uncertainty_score":0.0063723326},"labels":[],"label_agreement":null},{"id":"W2914184910","doi":"10.1007/s12032-019-1248-2","title":"Population-based assessment of the national comprehensive cancer network recommendations for baseline imaging of hepatocellular carcinoma","year":2019,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Oncology; Cohort; Radiology; Cancer; Population; Carcinoma; Epidemiology; Lung cancer","score_opus":0.07867631773559347,"score_gpt":0.3648041456132489,"score_spread":0.28612782787765545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914184910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8708814,0.0072043287,0.007425976,0.016390221,0.00042758157,0.0011950015,0.07437854,0.0004224335,0.021674568],"genre_scores_gemma":[0.9730592,0.0011412936,0.006683092,0.0013185402,0.00009102523,0.00054749893,0.016493352,0.00002785891,0.0006381547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598074,0.0017320534,0.00072376005,0.00039191396,0.0009579206,0.0002136075],"domain_scores_gemma":[0.9884404,0.002800423,0.004046503,0.00040547442,0.0035693217,0.00073776423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00828642,0.00027307915,0.0006397445,0.0031520142,0.00055156235,0.00091843196,0.0010795796,0.00093328534,0.001312447],"category_scores_gemma":[0.025993083,0.0002813259,0.00094562036,0.003330823,0.00021387999,0.00084323186,0.0008620215,0.0013340458,0.00031411258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001982346,0.00013086335,0.9720777,0.00015369071,0.0004110659,0.00004373619,0.00017866236,0.0007267722,0.00010936753,0.00017654704,0.0128343,0.012958988],"study_design_scores_gemma":[0.000047321642,0.00008918195,0.9942992,0.00014750498,0.00017945802,0.00008995233,0.00031760693,0.0015123031,0.00008113877,0.00014373696,0.0030744646,0.000018152761],"about_ca_topic_score_codex":0.05274812,"about_ca_topic_score_gemma":0.06875147,"teacher_disagreement_score":0.05274812,"about_ca_system_score_codex":0.0021712624,"about_ca_system_score_gemma":0.0031409198,"threshold_uncertainty_score":0.10488218},"labels":[],"label_agreement":null},{"id":"W2943739079","doi":"10.1007/s12032-019-1270-4","title":"N-Glycosylation in progression of skin cancer","year":2019,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"Major International Joint Research Programme; National Natural Science Foundation of China","keywords":"Skin cancer; Basal cell carcinoma; Cancer; Medicine; Glycosylation; Melanoma; Dermatology; Pathogenesis; Cancer research; Basal cell; Oncology; Bioinformatics; Immunology; Pathology; Biology; Internal medicine; Genetics","score_opus":0.06306833805052285,"score_gpt":0.4844157270600226,"score_spread":0.42134738900949975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943739079","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046642654,0.9990951,0.000071541275,0.00017646555,0.00019233463,0.0000016763362,0.000008044611,0.0000038562257,0.00040443594],"genre_scores_gemma":[0.00035034376,0.9988294,0.00010769639,0.00014646248,0.00022140033,0.000002385071,0.00001500896,7.290327e-7,0.00032657094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984837,0.000029770164,0.00001910232,0.00002842163,0.000053807264,0.000020551613],"domain_scores_gemma":[0.9997578,0.000104451654,0.000036820897,0.000008090213,0.000061749844,0.000031079813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060637295,0.0011415846,0.0013489691,0.0019926499,0.00023496931,0.0010602489,0.00076584343,0.0012096456,0.0022673449],"category_scores_gemma":[0.0006430283,0.00025967666,0.00036767963,0.0024134135,0.0005569649,0.0010267348,0.0008126074,0.002020123,0.0013706883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012824195,0.000069300004,0.0001730323,0.009328707,0.00006547578,0.00020200301,0.000027324006,0.0005271805,0.0013135194,0.0035547274,0.042815786,0.94179463],"study_design_scores_gemma":[0.000033656008,0.00009178592,0.0008365663,0.003430113,0.00014878616,0.0011478247,0.000051249637,0.0001826612,0.00049905095,0.0029876037,0.99056846,0.000022319298],"about_ca_topic_score_codex":0.0013866778,"about_ca_topic_score_gemma":0.0027562943,"teacher_disagreement_score":0.0022673449,"about_ca_system_score_codex":0.00084964227,"about_ca_system_score_gemma":0.0010169995,"threshold_uncertainty_score":0.007584989},"labels":[],"label_agreement":null},{"id":"W2976350229","doi":"10.1007/s12032-019-1317-6","title":"SOX4 is activated by C-MYC in prostate cancer","year":2019,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Natural Science Foundation of China","keywords":"SOX4; Oncogene; Cancer research; Prostate cancer; Cancer; Biology; Gene; Medicine; Gene expression; Internal medicine; Cell cycle; Promoter; Genetics","score_opus":0.020557177494425094,"score_gpt":0.3938727522268237,"score_spread":0.3733155747323986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976350229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518883,0.0017045882,0.00041069114,0.0001813292,0.00003986455,0.000007227109,0.00038586863,0.00003568851,0.0020460356],"genre_scores_gemma":[0.9970739,0.0003503322,0.00020222394,0.000039287035,0.000010662018,0.000004555479,0.00036057452,0.0000067984497,0.0019517323],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999739,0.000035361518,0.0000134934235,0.000029106268,0.00010467096,0.00007846089],"domain_scores_gemma":[0.999728,0.000042797787,0.00007962966,0.000019591303,0.000042308253,0.00008766541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018723492,0.00013859397,0.00017685,0.0005789241,0.0002691977,0.00051433756,0.00018653463,0.0002870858,0.0034793615],"category_scores_gemma":[0.00031299604,0.00017080453,0.0002586527,0.00038921167,0.00027800075,0.00019677333,0.00022521096,0.00037313803,0.00036425446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014745591,0.00012075061,0.052809507,0.00010809221,0.000080033526,0.0010727606,0.000087182,0.00033038732,0.93287677,0.00060143194,0.0007604353,0.009678006],"study_design_scores_gemma":[0.00009026643,0.0004935339,0.62544113,0.000030422316,0.00008041467,0.003916098,0.00071059796,0.003494265,0.35253543,0.0006599743,0.012524463,0.00002337976],"about_ca_topic_score_codex":0.0017719733,"about_ca_topic_score_gemma":0.0030393966,"teacher_disagreement_score":0.0034793615,"about_ca_system_score_codex":0.00046603687,"about_ca_system_score_gemma":0.00037533822,"threshold_uncertainty_score":0.011639595},"labels":[],"label_agreement":null},{"id":"W2996974361","doi":"10.1007/s12032-019-1335-4","title":"Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy","year":2019,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"National Institute for Health and Care Research; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Myoepithelial cell; Chemotherapy; Soft tissue; Internal medicine; Surgery; Interquartile range; Sarcoma; Carcinoma; Myoepithelioma; Oncology; Pathology; Immunohistochemistry","score_opus":0.013678002886541403,"score_gpt":0.32173787579245805,"score_spread":0.30805987290591663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996974361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995453,0.002965046,0.00009025808,0.00010165501,0.0000046168416,0.000009309126,0.0002797085,0.0000034020836,0.0010929069],"genre_scores_gemma":[0.9990953,0.00046153343,0.0000337079,0.00002916714,0.00001613396,0.00000427591,0.00028261502,0.0000015767291,0.00007577323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994129,0.00013920428,0.00012245994,0.000098322314,0.00013973152,0.000087389395],"domain_scores_gemma":[0.99799323,0.0003341999,0.001261593,0.000057472036,0.00014906416,0.00020448994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058334717,0.000090104935,0.00032461685,0.00043516073,0.00016286959,0.0004293478,0.00016605035,0.00024735832,0.0008895628],"category_scores_gemma":[0.0025874267,0.000045987636,0.00025808293,0.00078878505,0.00019346812,0.00041392373,0.00028035743,0.00026227382,0.00017553891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006030358,0.00006364215,0.9827551,0.000038751437,0.00007242975,0.0003018542,0.000064863525,0.00019976038,0.00047621646,0.00003032552,0.00011889362,0.015275004],"study_design_scores_gemma":[0.000011441592,0.00039023996,0.9978666,0.000020768472,0.0000372052,0.0009986295,0.00007422716,0.00018303195,0.00012152183,0.000034843026,0.00025786966,0.0000035938726],"about_ca_topic_score_codex":0.0007623618,"about_ca_topic_score_gemma":0.0013932037,"teacher_disagreement_score":0.0008895628,"about_ca_system_score_codex":0.00041664756,"about_ca_system_score_gemma":0.00019088777,"threshold_uncertainty_score":0.0030850768},"labels":[],"label_agreement":null},{"id":"W3016750340","doi":"10.1007/s12032-020-01367-9","title":"Targeting of oncogenic signaling pathways by berberine for treatment of colorectal cancer","year":2020,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Berberine and alkaloids research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Berberine; Colorectal cancer; Cancer; Medicine; Angiogenesis; Signal transduction; Cancer research; Metastasis; Pharmacology; Apoptosis; Inflammation; Biology; Internal medicine; Genetics","score_opus":0.09818715887388332,"score_gpt":0.4429074460089458,"score_spread":0.34472028713506253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016750340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026602446,0.9984628,0.00011015481,0.00013123077,0.00008741571,0.000006776291,0.00002347054,0.000009751746,0.0009024462],"genre_scores_gemma":[0.0017649265,0.9971138,0.00017603685,0.00015772723,0.000064451844,0.0000067449005,0.00004768607,0.0000015549099,0.00066701934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999223,0.000013220381,0.000009678309,0.00001648004,0.000025972526,0.0000123381315],"domain_scores_gemma":[0.9998902,0.00004835355,0.00002241036,0.0000036327435,0.000023966322,0.000011413195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003028478,0.0007269803,0.0011154473,0.0013195493,0.0001749274,0.00056426553,0.00056883396,0.00062019145,0.0035454973],"category_scores_gemma":[0.00033334678,0.00021456815,0.00051482656,0.0010539613,0.00025117194,0.00058364496,0.00039226757,0.0015485031,0.0012708083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026383245,0.00016257593,0.00014813017,0.022219568,0.00022628548,0.00020112164,0.000049180584,0.0005468433,0.006594616,0.0019184292,0.018959695,0.9487097],"study_design_scores_gemma":[0.00017098578,0.00047431618,0.0014347723,0.00385472,0.0005448161,0.0011184947,0.00004865734,0.00024430087,0.0027077692,0.0013038235,0.9880633,0.000034097895],"about_ca_topic_score_codex":0.0009132413,"about_ca_topic_score_gemma":0.002265477,"teacher_disagreement_score":0.0035454973,"about_ca_system_score_codex":0.00037661722,"about_ca_system_score_gemma":0.00050151546,"threshold_uncertainty_score":0.0118608475},"labels":[],"label_agreement":null},{"id":"W3032902009","doi":"10.1007/s12032-020-01386-6","title":"NUC-1031, use of ProTide technology to circumvent gemcitabine resistance: current status in clinical trials","year":2020,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Gemcitabine; Internal medicine; Medicine; Carboplatin; Oncology; Deoxycytidine; Cisplatin; Clinical trial; Population; Deoxycytidine kinase; Phases of clinical research; Gastroenterology; Chemotherapy","score_opus":0.4032888797597849,"score_gpt":0.6122757373894707,"score_spread":0.20898685762968583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032902009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005838546,0.99811316,0.00010542505,0.00019590787,0.00009709442,0.00001832979,0.00006820451,0.000010405913,0.0008075734],"genre_scores_gemma":[0.0032915068,0.99533397,0.00027156147,0.00042394048,0.00007384224,0.000024458648,0.00013385112,0.000003979839,0.00044295588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998155,0.000042611737,0.000031213138,0.000039496404,0.00004948529,0.000021706488],"domain_scores_gemma":[0.9995554,0.00028933902,0.00007564866,0.000009577376,0.00004175613,0.000028229748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008926708,0.00068748253,0.0022483626,0.0009789766,0.00015482403,0.0011568861,0.0009179198,0.0009082902,0.005514115],"category_scores_gemma":[0.0011646609,0.00021635955,0.0010351825,0.0012119614,0.0003733636,0.0007649956,0.00043527797,0.0018889658,0.0012143713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009684415,0.00016247794,0.0002574971,0.032349754,0.00040596616,0.00010391648,0.00003580772,0.0004553926,0.0015305193,0.0012219641,0.011255752,0.9512525],"study_design_scores_gemma":[0.00193399,0.0032805821,0.0040030596,0.02085617,0.0036698757,0.0016597402,0.00014092872,0.0005323918,0.0025137556,0.002436326,0.95889366,0.00007942526],"about_ca_topic_score_codex":0.0009905966,"about_ca_topic_score_gemma":0.0027236636,"teacher_disagreement_score":0.005514115,"about_ca_system_score_codex":0.00046221504,"about_ca_system_score_gemma":0.0010564729,"threshold_uncertainty_score":0.018446565},"labels":[],"label_agreement":null},{"id":"W3128570396","doi":"10.1007/s12032-021-01469-y","title":"Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma","year":2021,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Gemcitabine; Internal medicine; Capecitabine; Oncology; Proportional hazards model; Adenocarcinoma; Pancreatic cancer; Chemotherapy; Cancer; Surgery","score_opus":0.03525953342682862,"score_gpt":0.37127344855128785,"score_spread":0.3360139151244592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128570396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961403,0.00057318603,0.00021011461,0.00024912044,0.000014496786,0.000013831533,0.001930257,0.000009671412,0.00085905165],"genre_scores_gemma":[0.9984102,0.00014059269,0.00018532501,0.00004347702,0.000008087117,0.000007062843,0.0011123882,0.000005345987,0.0000875132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901986,0.00034025105,0.0002027659,0.00018649305,0.00011989585,0.00013059092],"domain_scores_gemma":[0.99521154,0.0013332847,0.002454787,0.00029507614,0.00031594106,0.00038940046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059058965,0.0001299199,0.00031316112,0.00087792735,0.00030573492,0.00081723626,0.00035742798,0.00042804788,0.0015085406],"category_scores_gemma":[0.007270655,0.00015196535,0.00039542382,0.0016462088,0.00032008765,0.00065777526,0.0005067528,0.0003866953,0.00027082622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048029074,0.00002675165,0.9940773,0.00002330603,0.00007757933,0.00013575378,0.00007194381,0.00044574458,0.00018557199,0.00005215369,0.0003296221,0.0040939045],"study_design_scores_gemma":[0.000016727,0.00015016877,0.99485415,0.000022449705,0.000050817933,0.0010140593,0.0005886585,0.0014258006,0.00022851535,0.00018478595,0.0014496177,0.000014276054],"about_ca_topic_score_codex":0.004303164,"about_ca_topic_score_gemma":0.011438401,"teacher_disagreement_score":0.004303164,"about_ca_system_score_codex":0.00079481147,"about_ca_system_score_gemma":0.0005488105,"threshold_uncertainty_score":0.008556247},"labels":[],"label_agreement":null},{"id":"W3201075189","doi":"10.1007/s12032-021-01585-9","title":"Direct oral anticoagulants in cancer patients: which help from the specialist hemostasis and thrombosis laboratory?","year":2021,"lang":"en","type":"letter","venue":"Medical Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Venous thromboembolism; Hematology; Hemostasis; Intensive care medicine; Thrombosis; Cancer; Venous thrombosis; Internal medicine","score_opus":0.03855149753870835,"score_gpt":0.33751423108134265,"score_spread":0.2989627335426343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201075189","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013330278,0.0020030679,0.00007291611,0.9872705,0.003935924,0.000012861906,0.00002451321,0.000012474274,0.0053346977],"genre_scores_gemma":[0.02619317,0.005385139,0.00082249625,0.894524,0.06612432,0.000053651132,0.000066246015,0.00003778942,0.006793186],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708253,0.0011877205,0.000539492,0.00022058375,0.0005296997,0.00043995705],"domain_scores_gemma":[0.99023587,0.0037532384,0.00088850834,0.00020368099,0.0018486608,0.0030699132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019914508,0.0005430016,0.0010909593,0.0012151211,0.0034611386,0.0038677172,0.0012692526,0.034725484,0.00837604],"category_scores_gemma":[0.02168369,0.0006904372,0.0009898433,0.0009035544,0.0016976643,0.0039276765,0.001200161,0.019151846,0.003446692],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016363227,0.00020645307,0.017815726,0.00017001682,0.000041622123,0.023327582,0.00046208405,0.0002726587,0.00041562918,0.0033394436,0.92370737,0.030077683],"study_design_scores_gemma":[0.0007698853,0.00046614415,0.026609525,0.0055744993,0.00017639346,0.080362275,0.005792879,0.00354284,0.0005434269,0.02357856,0.85231715,0.00026641804],"about_ca_topic_score_codex":0.014594957,"about_ca_topic_score_gemma":0.031325698,"teacher_disagreement_score":0.034725484,"about_ca_system_score_codex":0.0046171616,"about_ca_system_score_gemma":0.007332483,"threshold_uncertainty_score":0.033499956},"labels":[],"label_agreement":null},{"id":"W4210351854","doi":"10.1007/s12032-021-01637-0","title":"A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer","year":2022,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Windsor Clinical Research; University of Windsor; Western University","funders":"Canadian Institutes of Health Research; Windsor Cancer Centre Foundation","keywords":"Carboplatin; Regimen; Taxane; Medicine; Internal medicine; Oncology; Triple-negative breast cancer; Breast cancer; Chemotherapy; Clinical trial; Anthracycline; Paclitaxel; Chemotherapy regimen; Cancer; Cisplatin","score_opus":0.03430703195045192,"score_gpt":0.41606695792415455,"score_spread":0.3817599259737026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210351854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930394,0.0013096398,0.0003792305,0.0004963996,0.00015200899,0.002768565,0.0006216356,0.000030166819,0.0012030125],"genre_scores_gemma":[0.986985,0.001474626,0.0026731875,0.001009039,0.00026737584,0.0036472343,0.001878819,0.000029169874,0.0020355312],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992173,0.000436859,0.000034691115,0.00014406328,0.000041700067,0.00012541957],"domain_scores_gemma":[0.9987991,0.00026144972,0.00023395846,0.00011337881,0.00006660888,0.00052559195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002402597,0.0012265466,0.002378746,0.0005997436,0.0005369554,0.0012474373,0.00089923735,0.0015204592,0.005396673],"category_scores_gemma":[0.001810006,0.00061156903,0.0011984555,0.000715376,0.0014108415,0.001205635,0.0005189021,0.0037226176,0.00069439353],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9543486,0.02378429,0.001346878,0.0001478386,0.00033556417,0.000018953393,0.00005027432,0.00068404805,0.0060469857,0.00011856846,0.0004931263,0.0126249],"study_design_scores_gemma":[0.6844491,0.3092972,0.0035431634,0.000025528689,0.00035481644,0.00003064585,0.000035687586,0.00039318524,0.00090845657,0.00016059315,0.0007858086,0.000015796148],"about_ca_topic_score_codex":0.0015400229,"about_ca_topic_score_gemma":0.0031075221,"teacher_disagreement_score":0.005396673,"about_ca_system_score_codex":0.0010980222,"about_ca_system_score_gemma":0.0024393154,"threshold_uncertainty_score":0.01805365},"labels":[],"label_agreement":null},{"id":"W4223921537","doi":"10.1007/s12032-022-01702-2","title":"Telomerase gene therapy: a remission toward cancer","year":2022,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Telomerase; Telomere; Cancer; Telomerase reverse transcriptase; Biology; Cancer research; Cancer cell; Telomerase RNA component; Genetics; Gene","score_opus":0.19212612021986472,"score_gpt":0.4605155089703968,"score_spread":0.2683893887505321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223921537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041513304,0.9984297,0.000077707584,0.0004301937,0.00039846977,0.0000024755263,0.000012191848,0.000005491472,0.0006020951],"genre_scores_gemma":[0.00039863007,0.997982,0.000106558095,0.0005107871,0.00039911128,0.000005070766,0.00002108041,0.0000014589147,0.0005752307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998227,0.00004335704,0.00001920983,0.000031279782,0.00006258896,0.000020963915],"domain_scores_gemma":[0.999637,0.00021607068,0.00003637805,0.000011271715,0.00006605828,0.000033253244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008048111,0.0008970577,0.0016189712,0.0015212173,0.00030132482,0.0011408406,0.000893275,0.0014764948,0.004255229],"category_scores_gemma":[0.0010246533,0.00021111986,0.00046189417,0.0015650898,0.00056206103,0.0013394068,0.0007451288,0.0033033297,0.0021852572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013189127,0.00009258751,0.000111355774,0.013234689,0.00008397762,0.00011809202,0.00004611558,0.00032757854,0.0013252326,0.008019635,0.073314905,0.90319395],"study_design_scores_gemma":[0.000049748374,0.00009388866,0.00033371398,0.0033445477,0.00010729214,0.00045221287,0.000034549263,0.00007028792,0.00024062651,0.0025253831,0.99273515,0.000012560451],"about_ca_topic_score_codex":0.0007615453,"about_ca_topic_score_gemma":0.002137539,"teacher_disagreement_score":0.004255229,"about_ca_system_score_codex":0.000665065,"about_ca_system_score_gemma":0.00098127,"threshold_uncertainty_score":0.0142351985},"labels":[],"label_agreement":null},{"id":"W4225131621","doi":"10.1007/s12032-022-01664-5","title":"Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma","year":2022,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"H2020 Marie Skłodowska-Curie Actions; Horizon 2020 Framework Programme; Irish Research eLibrary","keywords":"Autocrine signalling; Antibody; Anoikis; Receptor; Cancer research; Tongue; Biology; Cancer cell; Cancer; Immunology; Internal medicine; Medicine; Pathology","score_opus":0.02027798438148882,"score_gpt":0.3258699789729688,"score_spread":0.30559199459148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225131621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948437,0.007162265,0.00071416056,0.00011933033,0.00002204387,0.00002577315,0.00014305048,0.000028928356,0.0023001083],"genre_scores_gemma":[0.99617106,0.002455631,0.00046926827,0.000028125367,0.000013751569,0.000010974502,0.00012740161,0.00000200912,0.00072181685],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993265,0.000016641685,0.000008143325,0.0000070639326,0.000019345238,0.000016217855],"domain_scores_gemma":[0.9998504,0.000047348818,0.00003419996,0.000019416022,0.000022624721,0.000025990083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015368397,0.0001666318,0.0001436141,0.0004073989,0.00010652817,0.00021117985,0.00011184265,0.00019851686,0.0016661533],"category_scores_gemma":[0.0001548816,0.000067848945,0.00017914886,0.00013602311,0.00019453416,0.00010540827,0.00012319589,0.00028368342,0.00022295777],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008527493,0.00011830713,0.008628823,0.00019750404,0.000023753919,0.00097585423,0.00005266164,0.00007882773,0.983337,0.0002214735,0.00008620541,0.0054267743],"study_design_scores_gemma":[0.00016728259,0.003514834,0.21565089,0.000060562692,0.00018852497,0.010330169,0.0003529708,0.001229743,0.7579144,0.0005421104,0.010031952,0.00001649586],"about_ca_topic_score_codex":0.00031820274,"about_ca_topic_score_gemma":0.00027895308,"teacher_disagreement_score":0.0016661533,"about_ca_system_score_codex":0.00011053969,"about_ca_system_score_gemma":0.00011377555,"threshold_uncertainty_score":0.0055738688},"labels":[],"label_agreement":null},{"id":"W4280489063","doi":"10.1007/s12032-022-01695-y","title":"Cell line models for drug discovery in PIK3CA-mutated colorectal cancers","year":2022,"lang":"en","type":"article","venue":"Medical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"KRAS; Colorectal cancer; Cancer research; Microsatellite instability; Cancer; Cell culture; PI3K/AKT/mTOR pathway; Mutation; Trametinib; Medicine; Biology; Internal medicine; Oncology; Genetics; MAPK/ERK pathway; Kinase; Gene; Signal transduction; Microsatellite","score_opus":0.012353814222703065,"score_gpt":0.2948935720375525,"score_spread":0.28253975781484947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280489063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8618272,0.013273774,0.053804483,0.0044038184,0.0015538479,0.0013843618,0.03939848,0.0012806545,0.023073466],"genre_scores_gemma":[0.92394406,0.007230469,0.021366179,0.0007435059,0.0001216813,0.0012535694,0.020609057,0.00013962889,0.02459177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995552,0.00009187499,0.00005789495,0.00006588302,0.00015604231,0.00007299404],"domain_scores_gemma":[0.99971884,0.00008114798,0.000031768763,0.00004742234,0.00007082229,0.00004992307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057900546,0.0005445412,0.0007095287,0.001180237,0.00055886677,0.00094556273,0.0005851304,0.0008782633,0.0052511566],"category_scores_gemma":[0.00038555896,0.0002425379,0.0007502654,0.0010052286,0.00028837487,0.0004517324,0.0003011542,0.0020232094,0.0024391783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018568658,0.0008983246,0.0030684178,0.00047672042,0.0001732391,0.0012881418,0.00026593095,0.0019073312,0.9604472,0.006159554,0.0109216105,0.012536756],"study_design_scores_gemma":[0.000531638,0.0022078685,0.0058410205,0.000052627798,0.00037235615,0.0020540599,0.00026392058,0.00833205,0.9102328,0.0007494309,0.06931109,0.000051041065],"about_ca_topic_score_codex":0.0038944469,"about_ca_topic_score_gemma":0.006465137,"teacher_disagreement_score":0.0052511566,"about_ca_system_score_codex":0.0008446882,"about_ca_system_score_gemma":0.00062082335,"threshold_uncertainty_score":0.01756692},"labels":[],"label_agreement":null},{"id":"W4282935413","doi":"10.1007/s12032-022-01711-1","title":"RETRACTED ARTICLE: Artificial intelligence and machine learning in precision and genomic medicine","year":2022,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":408,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Precision medicine; Artificial intelligence; Personalized medicine; Machine learning; Health care; Computer science; Inference; Biobank; Process (computing); Data science; Deep learning; Personalization; Bioinformatics; Medicine; Biology","score_opus":0.08610320766114256,"score_gpt":0.39310514217246,"score_spread":0.30700193451131746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282935413","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023930735,0.46050394,0.0013662514,0.08357377,0.44854715,0.000044447388,0.00026870394,0.00011535506,0.005341085],"genre_scores_gemma":[0.0033537445,0.6035699,0.0017000489,0.10114044,0.25892028,0.000088688386,0.0005202107,0.0001431457,0.030563427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979329,0.0004167692,0.0003137373,0.00026861057,0.0008558688,0.00021219502],"domain_scores_gemma":[0.9892181,0.0048749717,0.0006323587,0.000266791,0.0041738288,0.0008340094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037945474,0.0013094853,0.0017593062,0.0031868687,0.0010284088,0.0029126864,0.0030080816,0.006482914,0.018884378],"category_scores_gemma":[0.015239403,0.00040854598,0.0014420253,0.0035267798,0.0021012272,0.005155496,0.0020650516,0.009004969,0.014176112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008903981,0.000028163515,0.00012709062,0.0035493297,0.00005450733,0.00027750328,0.000068657544,0.00018419644,0.0002615995,0.005226188,0.8633872,0.1267465],"study_design_scores_gemma":[0.000020044023,0.00005088217,0.0002573138,0.0015496165,0.00004237565,0.00072431855,0.000036218622,0.00009706963,0.00018535015,0.0023608513,0.99465644,0.000019616524],"about_ca_topic_score_codex":0.0019057738,"about_ca_topic_score_gemma":0.0028780212,"teacher_disagreement_score":0.018884378,"about_ca_system_score_codex":0.0018282735,"about_ca_system_score_gemma":0.003755439,"threshold_uncertainty_score":0.063174605},"labels":[],"label_agreement":null},{"id":"W4297963662","doi":"10.1007/s12032-022-01829-2","title":"Are we overtreating stage I triple-negative breast cancer in Ontario? A population-based retrospective epidemiological analysis using the ICES database","year":2022,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Windsor Clinical Research; Windsor Regional Hospital; University of Windsor; Western University","funders":"","keywords":"Medicine; Hazard ratio; Triple-negative breast cancer; Internal medicine; Oncology; Chemotherapy; Stage (stratigraphy); Breast cancer; Confidence interval; Proportional hazards model; Population; Cancer; Database","score_opus":0.04282111441218178,"score_gpt":0.35859407431959694,"score_spread":0.31577295990741516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297963662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874313,0.0007266768,0.0000979248,0.00038320414,0.000009936047,0.000031024232,0.009489506,0.0000067844335,0.0018236729],"genre_scores_gemma":[0.9954717,0.00063631206,0.00009464584,0.00010675624,0.000009281686,0.000021473748,0.003011072,0.0000047336953,0.00064399384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877304,0.00013084649,0.00014603426,0.0002287099,0.00034523924,0.00037600342],"domain_scores_gemma":[0.996494,0.00025855392,0.0017104183,0.0002953423,0.0008109712,0.0004306243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007283502,0.0002859977,0.00047949003,0.0013398476,0.0015340581,0.0012269077,0.001025806,0.00047943773,0.0017858392],"category_scores_gemma":[0.0037622063,0.0005636732,0.0007957306,0.006537874,0.0005776109,0.00061038666,0.0007836863,0.00063459674,0.00019498727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003660381,0.0000095735595,0.99867696,0.000012508527,0.000046348403,0.000033375483,0.00020905182,0.000024437475,0.000048527472,0.000035407462,0.00030391954,0.0005633332],"study_design_scores_gemma":[0.0000036248541,0.000009708072,0.9988745,0.00001449166,0.000033029217,0.000030155063,0.00046439917,0.000065138294,0.000011822562,0.000013422294,0.00047618806,0.0000035974856],"about_ca_topic_score_codex":0.9611802,"about_ca_topic_score_gemma":0.97266823,"teacher_disagreement_score":0.03881979,"about_ca_system_score_codex":0.009237249,"about_ca_system_score_gemma":0.014362829,"threshold_uncertainty_score":0.07809675},"labels":[],"label_agreement":null},{"id":"W4297983491","doi":"10.1007/s12032-022-01772-2","title":"RETRACTED ARTICLE: TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy","year":2022,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":8,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"FOXP3; Cancer research; Cancer; Immunology; Cancer immunotherapy; Agonist; Immunotherapy; Immunopharmacology; Medicine; Tumor necrosis factor alpha; Effector; Downregulation and upregulation; Receptor; Pharmacology; Biology; Internal medicine; Immune system","score_opus":0.045760209823650116,"score_gpt":0.37637672543935596,"score_spread":0.3306165156157058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297983491","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038338668,0.40042454,0.00087677356,0.04488947,0.54862624,0.000045459157,0.00027929747,0.00009859038,0.004376207],"genre_scores_gemma":[0.0046775495,0.46385735,0.0013011836,0.11680825,0.36780113,0.00006368106,0.00059215614,0.0000897796,0.04480882],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986364,0.00022011931,0.00023223861,0.00014668913,0.00059868535,0.000165838],"domain_scores_gemma":[0.99734384,0.00085647457,0.00028687294,0.00007576602,0.001082097,0.0003550559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026398683,0.0013045421,0.001949045,0.0021919277,0.0008395039,0.0022894212,0.0021425642,0.005938527,0.010088044],"category_scores_gemma":[0.0058632675,0.000425733,0.0011318506,0.0015039659,0.001399331,0.0026819038,0.00156501,0.006154266,0.008807928],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016745448,0.000029747784,0.00009021507,0.002695605,0.000049185957,0.0006043875,0.00004264662,0.000109824556,0.0008523746,0.0015267783,0.8484822,0.14534955],"study_design_scores_gemma":[0.000051618426,0.00011114567,0.0002304086,0.00075238536,0.00007117808,0.0012426288,0.000024643006,0.0000654309,0.00040132078,0.0007339649,0.99629885,0.000016541786],"about_ca_topic_score_codex":0.0012619086,"about_ca_topic_score_gemma":0.0028643517,"teacher_disagreement_score":0.010088044,"about_ca_system_score_codex":0.0014294962,"about_ca_system_score_gemma":0.00254469,"threshold_uncertainty_score":0.03374791},"labels":[],"label_agreement":null},{"id":"W4297989875","doi":"10.1007/s12032-022-01836-3","title":"RETRACTED ARTICLE: Niosomes: a novel targeted drug delivery system for cancer","year":2022,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":97,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Niosome; Nanocarriers; Drug delivery; Drug; Nanotechnology; Pharmacology; Targeted drug delivery; Medicine; Vesicle; Materials science; Chemistry","score_opus":0.20406736540154058,"score_gpt":0.5081526482652872,"score_spread":0.3040852828637466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297989875","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030327882,0.40222725,0.0036747833,0.07701212,0.5001372,0.00013744035,0.0008584634,0.00032904092,0.012591013],"genre_scores_gemma":[0.021423766,0.56366146,0.0051595573,0.11814388,0.11621361,0.00015396767,0.0017292465,0.0002563407,0.17325823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99883837,0.00013927108,0.00018932721,0.000118310156,0.0005623016,0.0001525314],"domain_scores_gemma":[0.99828416,0.00041073927,0.00019734944,0.000067866764,0.0008506585,0.00018929616],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020436777,0.0009179631,0.0013364784,0.0014512961,0.000888924,0.0017590199,0.0019751997,0.004563479,0.010843639],"category_scores_gemma":[0.0043556956,0.00034655313,0.0007381169,0.0013757934,0.0012729609,0.0027652741,0.0019021509,0.0040530693,0.0072185034],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002271226,0.0000653644,0.00021661237,0.005679831,0.000073106574,0.0011553359,0.00017506792,0.00017444196,0.004568477,0.0038903353,0.7190073,0.26476696],"study_design_scores_gemma":[0.000024682598,0.00010210468,0.00024520117,0.00049575884,0.000066686895,0.0010997641,0.000047125563,0.00007171154,0.0021778943,0.00073146605,0.99491584,0.000021942651],"about_ca_topic_score_codex":0.0017907686,"about_ca_topic_score_gemma":0.0034381857,"teacher_disagreement_score":0.99543655,"about_ca_system_score_codex":0.00107401,"about_ca_system_score_gemma":0.0033139312,"threshold_uncertainty_score":0.036275566},"labels":[],"label_agreement":null},{"id":"W4297989889","doi":"10.1007/s12032-022-01771-3","title":"RETRACTED ARTICLE: Anti-cancer activity of human gastrointestinal bacteria","year":2022,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Dysbiosis; Cancer; Immune system; Gastrointestinal cancer; Biology; Immunology; Gastrointestinal tract; Gut flora; Cancer prevention; Disease; Colorectal cancer; Medicine; Internal medicine","score_opus":0.058360464058255235,"score_gpt":0.41559390094286297,"score_spread":0.35723343688460774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297989889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006458617,0.50517666,0.0008043738,0.04141475,0.44790903,0.000033790202,0.00031546477,0.00009529777,0.0036046903],"genre_scores_gemma":[0.0067987232,0.6158676,0.0014261394,0.084928796,0.24508514,0.000060324288,0.000711881,0.000091061505,0.045030385],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987185,0.00017447365,0.000201783,0.00014337242,0.0006072951,0.00015456448],"domain_scores_gemma":[0.9973653,0.00090588396,0.0002794974,0.00008901477,0.0010023679,0.0003579227],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024783765,0.001302256,0.0017730397,0.0018501475,0.0007312594,0.0020249458,0.00214998,0.005416147,0.008578751],"category_scores_gemma":[0.0065061618,0.00034752733,0.00091445807,0.0016590253,0.0013710264,0.0019184904,0.0017346827,0.004771793,0.0060224086],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027708104,0.000042762458,0.00014622298,0.0046634898,0.00007418868,0.0008383033,0.00006561042,0.0001378241,0.001479026,0.0021091795,0.7521742,0.23799203],"study_design_scores_gemma":[0.000044134096,0.00011684612,0.00036524792,0.00073117466,0.00007230102,0.0010781599,0.000029550905,0.0000461673,0.00072316057,0.00070177234,0.9960743,0.000017149938],"about_ca_topic_score_codex":0.0015561404,"about_ca_topic_score_gemma":0.0026175377,"teacher_disagreement_score":0.99458385,"about_ca_system_score_codex":0.0013715769,"about_ca_system_score_gemma":0.002724467,"threshold_uncertainty_score":0.028698742},"labels":[],"label_agreement":null},{"id":"W4304809280","doi":"10.1007/s12032-022-01838-1","title":"RETRACTED ARTICLE: In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriers","year":2022,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":14,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Nanoparticle; Nuclear chemistry; Fourier transform infrared spectroscopy; Materials science; Particle size; Drug carrier; Cytotoxicity; Superparamagnetism; Drug delivery; In vitro; Nanotechnology; Chemistry; Chemical engineering; Biochemistry","score_opus":0.01216333093162974,"score_gpt":0.28894079213261853,"score_spread":0.2767774612009888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304809280","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031419773,0.01686526,0.008607214,0.12671988,0.80642843,0.000082083,0.0013152998,0.001211035,0.007351003],"genre_scores_gemma":[0.2620452,0.03763294,0.018095996,0.10271175,0.1980825,0.00020315162,0.005739543,0.0018171058,0.3736718],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986802,0.00013014516,0.00018396761,0.00014878811,0.0006890096,0.00016797232],"domain_scores_gemma":[0.995001,0.0014429382,0.00031679828,0.00029200807,0.0024457884,0.0005013464],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001935204,0.0009134101,0.0011225155,0.0013325975,0.0015661683,0.001573629,0.00197603,0.0056703114,0.010156817],"category_scores_gemma":[0.007476231,0.00046828564,0.0007047743,0.0007023337,0.0010644561,0.0012363825,0.00097214733,0.0027427163,0.006340078],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013539563,0.0002577943,0.0018516876,0.001393785,0.00015783498,0.013348867,0.00062965415,0.00060059817,0.044988006,0.0026739256,0.83777905,0.09496487],"study_design_scores_gemma":[0.00008575626,0.00041221027,0.003924965,0.00020269498,0.00024316997,0.00879902,0.00034158168,0.0014253978,0.07737939,0.0014963376,0.9055561,0.00013343868],"about_ca_topic_score_codex":0.0031573586,"about_ca_topic_score_gemma":0.0036765155,"teacher_disagreement_score":0.9943297,"about_ca_system_score_codex":0.0017632642,"about_ca_system_score_gemma":0.0020189725,"threshold_uncertainty_score":0.033977926},"labels":[],"label_agreement":null},{"id":"W4313400248","doi":"10.1007/s12032-022-01867-w","title":"FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes","year":2022,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Science and Technology Program of Guizhou Province; Guizhou Medical University; National Natural Science Foundation of China","keywords":"PKM2; Glycolysis; Cancer research; Gene knockdown; Biology; Anaerobic glycolysis; Pyruvate kinase; Gene silencing; Leukemia; Downregulation and upregulation; Cell biology; Molecular biology; Apoptosis; Biochemistry; Gene; Immunology; Enzyme","score_opus":0.023161985184550194,"score_gpt":0.2865307003146302,"score_spread":0.26336871513008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313400248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97940105,0.004804672,0.004655423,0.0013625921,0.0001834287,0.00006670301,0.0016298615,0.0007711353,0.007125113],"genre_scores_gemma":[0.9900253,0.0009246698,0.0014558325,0.00025732568,0.000035033132,0.00004147896,0.0014714918,0.000062163104,0.005726718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985826,0.000017715114,0.0000062544905,0.000030526477,0.000029580675,0.000057752284],"domain_scores_gemma":[0.99988675,0.00001174948,0.00003464358,0.000009204173,0.000011847721,0.000045771416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021561632,0.000396058,0.00028521783,0.00042373748,0.00019987182,0.0004207236,0.00024432995,0.00025940817,0.0035304017],"category_scores_gemma":[0.0001550814,0.00015759877,0.00027829353,0.00017878044,0.00025767993,0.00018383433,0.00025275868,0.0009225194,0.00061840215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004314039,0.00011301182,0.00038112927,0.000040709907,0.000009627859,0.00004499803,0.0000126673185,0.00013572932,0.99387556,0.00023775327,0.00045477183,0.00426271],"study_design_scores_gemma":[0.000071973074,0.00063257385,0.012065955,0.000010032878,0.00002607662,0.0002153602,0.000058657963,0.0009877419,0.9783068,0.00014151345,0.007475011,0.000008272079],"about_ca_topic_score_codex":0.0008138973,"about_ca_topic_score_gemma":0.0012533732,"teacher_disagreement_score":0.0035304017,"about_ca_system_score_codex":0.0006230049,"about_ca_system_score_gemma":0.00029720066,"threshold_uncertainty_score":0.011810422},"labels":[],"label_agreement":null},{"id":"W4316925850","doi":"10.1007/s12032-022-01930-6","title":"RETRACTED ARTICLE: Molecular and therapeutic effect of CRISPR in treating cancer","year":2023,"lang":"en","type":"review","venue":"Medical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"CRISPR; Genome editing; Biology; Epigenetics; Gene; Cancer; Genome; Computational biology; DNA repair; Genetics; Cancer cell; Cancer research","score_opus":0.07365655161423457,"score_gpt":0.4941140225092025,"score_spread":0.42045747089496793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316925850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082355936,0.7637119,0.0011927007,0.019901516,0.2002711,0.000058352896,0.00032692033,0.00015207035,0.013561783],"genre_scores_gemma":[0.005446935,0.8729063,0.0011134542,0.023374181,0.04952928,0.000049896604,0.00061037985,0.0000797049,0.046889782],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994529,0.00007946756,0.00007492683,0.000077913355,0.0002281989,0.000086610315],"domain_scores_gemma":[0.99884135,0.00031978864,0.000099010926,0.000029642717,0.00053128373,0.00017894263],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010176688,0.00094277854,0.0010101276,0.0016720649,0.00059976993,0.0013846112,0.0015450007,0.0032862832,0.016402641],"category_scores_gemma":[0.0028226075,0.00022189085,0.00078848714,0.0013551571,0.0006815146,0.0018618203,0.0011651547,0.0035477083,0.008830721],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016012478,0.00005213066,0.00014233211,0.0060419915,0.000056960023,0.0007815444,0.00008023326,0.00022710794,0.0022891513,0.003139814,0.60649025,0.38053837],"study_design_scores_gemma":[0.00001849387,0.00007715854,0.00022320922,0.0008270076,0.000042470056,0.0015325497,0.000026705156,0.000054267523,0.0007342263,0.00062817306,0.9958223,0.000013423779],"about_ca_topic_score_codex":0.0010853466,"about_ca_topic_score_gemma":0.0018488228,"teacher_disagreement_score":0.9967137,"about_ca_system_score_codex":0.00075707433,"about_ca_system_score_gemma":0.0013516073,"threshold_uncertainty_score":0.054872274},"labels":[],"label_agreement":null},{"id":"W4388895519","doi":"10.1007/s12032-023-02228-x","title":"Comprehensive genomic profiling for oncological advancements by precision medicine","year":2023,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Profiling (computer programming); Precision medicine; Hematology; Computational biology; Medicine; Internal medicine; Genomic medicine; Medical physics; Bioinformatics; Biology; Computer science; Pathology","score_opus":0.09306962289480841,"score_gpt":0.43958301887761103,"score_spread":0.3465133959828026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388895519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007836693,0.99789727,0.0004531535,0.0005425309,0.00023945225,0.000005193416,0.000042743413,0.00001568783,0.00072546996],"genre_scores_gemma":[0.0008297453,0.99709713,0.0005863929,0.000614866,0.00024809327,0.000009132837,0.00007783445,0.00000261736,0.0005342218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997396,0.00006414333,0.000021564292,0.00005119256,0.00009560453,0.000027867918],"domain_scores_gemma":[0.9994311,0.00033353525,0.000055365523,0.000022183081,0.00011761728,0.00004020804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011705591,0.0009762546,0.0014556956,0.0015542982,0.00016073498,0.0010550206,0.0008093085,0.0010270845,0.0028550583],"category_scores_gemma":[0.0014554828,0.0002480919,0.0005541386,0.0013939907,0.00049653056,0.00092084386,0.0008309527,0.002120057,0.0014982753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006794306,0.000037150847,0.00017370598,0.0071748737,0.00012150408,0.00009612351,0.00001957912,0.00038155995,0.0017138199,0.0053566424,0.0371949,0.9476622],"study_design_scores_gemma":[0.000032756314,0.00008798583,0.0007306559,0.0030795678,0.00020830544,0.00058904855,0.00003195659,0.00018977969,0.000952706,0.004777627,0.9892958,0.000023843797],"about_ca_topic_score_codex":0.000865517,"about_ca_topic_score_gemma":0.0021271736,"teacher_disagreement_score":0.0028550583,"about_ca_system_score_codex":0.0007281399,"about_ca_system_score_gemma":0.0011118731,"threshold_uncertainty_score":0.009551108},"labels":[],"label_agreement":null},{"id":"W4399850192","doi":"10.1007/s12032-024-02417-2","title":"Dissecting the multifaceted roles of autophagy in cancer initiation, growth, and metastasis: from molecular mechanisms to therapeutic applications","year":2024,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Autophagy; Biology; Tumor microenvironment; Context (archaeology); Carcinogenesis; Cancer research; Cancer; Cell biology; Cancer cell; Immunology; Immune system; Apoptosis; Genetics","score_opus":0.019543037517276787,"score_gpt":0.3643738667088487,"score_spread":0.34483082919157193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399850192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26792547,0.67022675,0.022693561,0.028850758,0.0007103827,0.00006891437,0.00030807292,0.0001657252,0.009050399],"genre_scores_gemma":[0.7383828,0.24697557,0.009945363,0.002268772,0.00044733332,0.00005116554,0.000114638555,0.000023052267,0.001791138],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996394,0.00009389147,0.000028206956,0.000058673693,0.00010013308,0.00007967478],"domain_scores_gemma":[0.99954563,0.0001506075,0.00010074829,0.000049015925,0.00007325465,0.00008057381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001317013,0.00053180614,0.00090256834,0.0013736325,0.0007508933,0.0027794484,0.00054611923,0.0011023144,0.0007052362],"category_scores_gemma":[0.0006009406,0.00028804978,0.0005539179,0.0006924793,0.002705771,0.0036235375,0.0014157493,0.0022329043,0.00015227037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017127647,0.00040576488,0.020407025,0.0046941615,0.00032350814,0.0013569676,0.001080311,0.006954074,0.455742,0.15942039,0.008412449,0.33949053],"study_design_scores_gemma":[0.00024012847,0.0023308247,0.09468973,0.0027107673,0.00066959206,0.006923064,0.008239934,0.026576973,0.3192012,0.33750433,0.2005526,0.00036078214],"about_ca_topic_score_codex":0.00069123413,"about_ca_topic_score_gemma":0.0022346165,"teacher_disagreement_score":0.0027794484,"about_ca_system_score_codex":0.0013589751,"about_ca_system_score_gemma":0.0019003006,"threshold_uncertainty_score":0.009860098},"labels":[],"label_agreement":null},{"id":"W4400177573","doi":"10.1007/s12032-024-02437-y","title":"The role of histamine and its receptors in breast cancer: from pathology to therapeutic targets","year":2024,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. Georges-L.-Dumont University Hospital Centre; Atlantic Cancer Research Institute","funders":"","keywords":"Histamine; Hematology; Breast cancer; Internal medicine; Medicine; Receptor; Histamine receptor; Cancer; Pathology; Oncology","score_opus":0.014716750529139835,"score_gpt":0.30440012517831444,"score_spread":0.2896833746491746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400177573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037471676,0.99903536,0.000050921495,0.00030621333,0.00027456533,0.0000016316851,0.0000072681937,0.000002663334,0.00028385024],"genre_scores_gemma":[0.00030740496,0.9984769,0.000062717874,0.00025223222,0.0005511029,0.000002403901,0.000012503934,5.458458e-7,0.00033418465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998098,0.000034606444,0.000019307108,0.000030978445,0.000081101825,0.000024229335],"domain_scores_gemma":[0.9995864,0.00019377447,0.000059628164,0.000010018016,0.00009504784,0.000055125845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007641347,0.0008803009,0.0013779183,0.0014266893,0.00019406377,0.0011547343,0.00084003643,0.0015791955,0.0031608904],"category_scores_gemma":[0.00090854504,0.00025228725,0.00037222318,0.001600229,0.0005690267,0.0015132178,0.000807087,0.0023443387,0.0017224369],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019461584,0.00007322781,0.0001963584,0.012201104,0.00008911446,0.00027036,0.000045013225,0.0005175487,0.0023321863,0.0030662196,0.076848745,0.9041654],"study_design_scores_gemma":[0.00005500039,0.00017666229,0.0009277754,0.0027474833,0.00011923579,0.0011456568,0.00006586848,0.00015152257,0.00030040552,0.0020863325,0.99220383,0.000020201023],"about_ca_topic_score_codex":0.00086877786,"about_ca_topic_score_gemma":0.0018327807,"teacher_disagreement_score":0.0031608904,"about_ca_system_score_codex":0.0006400348,"about_ca_system_score_gemma":0.0009915115,"threshold_uncertainty_score":0.010574222},"labels":[],"label_agreement":null},{"id":"W4402599692","doi":"10.1007/s12032-024-02441-2","title":"Incidence of lymphedema related to various cancers","year":2024,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Breast Cancer Foundation; McGill University Health Centre","funders":"","keywords":"Medicine; Incidence (geometry); Lymphedema; MEDLINE; Psychosocial; Cochrane Library; Cancer; Breast cancer; Quality of life (healthcare); Internal medicine; Intensive care medicine; Physical therapy; Meta-analysis; Nursing","score_opus":0.04058360327355868,"score_gpt":0.43258148339441965,"score_spread":0.39199788012086095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402599692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061391795,0.99874216,0.000034372413,0.00005356863,0.000037445076,0.000019395222,0.00019667455,0.0000022391278,0.00030019018],"genre_scores_gemma":[0.0089200325,0.9905338,0.00013115832,0.00007947283,0.00005468139,0.00003868877,0.00016833964,0.0000013997553,0.00007234724],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997189,0.00066966325,0.0010337521,0.00029837125,0.0007160797,0.00009312931],"domain_scores_gemma":[0.9943089,0.0037263136,0.0014069988,0.00006138893,0.00043869953,0.000057832363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022273182,0.0007368564,0.002762854,0.009656098,0.00022763078,0.001447712,0.0007513006,0.00066488155,0.0031264233],"category_scores_gemma":[0.008966689,0.00039378088,0.0034688292,0.010753028,0.00044246053,0.0011559526,0.000843612,0.00066179427,0.00024009857],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026047617,0.000029677562,0.007326026,0.6829002,0.008246705,0.0002116572,0.00029308448,0.00020563882,0.00037892262,0.0007442855,0.006098164,0.29330525],"study_design_scores_gemma":[0.00026212,0.0005199067,0.09532309,0.61913013,0.05860605,0.0072023743,0.0012712019,0.00027804144,0.0009580493,0.0016598977,0.21466003,0.00012916015],"about_ca_topic_score_codex":0.003802028,"about_ca_topic_score_gemma":0.0066884807,"teacher_disagreement_score":0.009656098,"about_ca_system_score_codex":0.0011249224,"about_ca_system_score_gemma":0.001709587,"threshold_uncertainty_score":0.011779368},"labels":[],"label_agreement":null},{"id":"W4402826410","doi":"10.1007/s12032-024-02504-4","title":"Personalized treatment approach for HER2-positive metastatic breast cancer","year":2024,"lang":"en","type":"review","venue":"Medical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Science and Engineering Research Board","keywords":"Hematology; Internal medicine; Breast cancer; Metastatic breast cancer; Oncology; Medicine; Cancer; Trastuzumab","score_opus":0.20989891219432807,"score_gpt":0.5502231872662202,"score_spread":0.3403242750718921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402826410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007809635,0.99892116,0.00010793363,0.00026087565,0.0001342614,0.00000396668,0.000017533823,0.000005448114,0.00047082524],"genre_scores_gemma":[0.00084997027,0.99803597,0.00019648432,0.00039925674,0.00013759069,0.000006033218,0.000040305833,0.000001353732,0.00033300425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998448,0.000038558734,0.000019641186,0.000030365358,0.00004838927,0.00001820932],"domain_scores_gemma":[0.99979824,0.00012094304,0.000029467685,0.0000051933753,0.000033915672,0.000012230677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047122219,0.0006946043,0.0014297285,0.001281073,0.00018348114,0.00081705215,0.0008334844,0.0007992789,0.0039976626],"category_scores_gemma":[0.00077047304,0.0001969973,0.0007817757,0.0009789505,0.00023826826,0.00075736037,0.0005646621,0.0018406949,0.0010136714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000853888,0.00006830856,0.00014687849,0.015491108,0.00022394268,0.00011151486,0.000025916768,0.00046992555,0.0007634311,0.0021636891,0.02876415,0.9516857],"study_design_scores_gemma":[0.000121427904,0.00021191545,0.0014495015,0.010677228,0.0008529034,0.0012397505,0.000049013466,0.00035806667,0.000483729,0.0033325201,0.98119223,0.00003166359],"about_ca_topic_score_codex":0.00085982593,"about_ca_topic_score_gemma":0.0026831555,"teacher_disagreement_score":0.0039976626,"about_ca_system_score_codex":0.0005258319,"about_ca_system_score_gemma":0.0006503906,"threshold_uncertainty_score":0.013373494},"labels":[],"label_agreement":null},{"id":"W4403388893","doi":"10.1007/s12032-024-02449-8","title":"Expert-consensus on lymphedema surgeries: candidacy, prehabilitation, and postoperative care","year":2024,"lang":"en","type":"editorial","venue":"Medical Oncology","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Breast Cancer Foundation; McGill University Health Centre","funders":"","keywords":"Prehabilitation; Candidacy; Lymphedema; Medicine; MEDLINE; Physical therapy; Intensive care medicine; Internal medicine; Surgery; Cancer","score_opus":0.010865110801565556,"score_gpt":0.3490442979428858,"score_spread":0.3381791871413202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403388893","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017654456,0.026476089,0.00011953473,0.057131555,0.914959,0.000024646504,0.000058560374,0.000019010211,0.0011938936],"genre_scores_gemma":[0.00030275944,0.023514874,0.00021114298,0.04573148,0.92674494,0.000056342684,0.000065814886,0.00002479978,0.003347822],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98620355,0.0039208713,0.0027466165,0.0012956596,0.005040172,0.0007930736],"domain_scores_gemma":[0.92515707,0.03504181,0.0041852165,0.0011686365,0.028730884,0.0057164547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017600209,0.0028230813,0.0050899643,0.0059952755,0.0034188644,0.008171329,0.0048104804,0.024209682,0.01551033],"category_scores_gemma":[0.06300272,0.001528251,0.004324612,0.0029414196,0.002818281,0.0054182764,0.0033139265,0.025368633,0.010501526],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027899177,0.000008670782,0.000016093307,0.0007834617,0.000033542547,0.000046495243,0.000013300697,0.000017751952,0.000021844606,0.00022403718,0.99045426,0.0083527025],"study_design_scores_gemma":[0.00015315918,0.000022966859,0.00024586826,0.0061650355,0.0001825297,0.00023095975,0.00005930734,0.00009732726,0.000067571105,0.0016039179,0.99113715,0.000034202934],"about_ca_topic_score_codex":0.00412744,"about_ca_topic_score_gemma":0.011671456,"teacher_disagreement_score":0.024209682,"about_ca_system_score_codex":0.0052445554,"about_ca_system_score_gemma":0.009967465,"threshold_uncertainty_score":0.093079925},"labels":[],"label_agreement":null},{"id":"W4403393856","doi":"10.1007/s12032-024-02457-8","title":"Consensus statement on non-cancer-related risk factors for development of secondary lymphedema","year":2024,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Hematology; Statement (logic); Medicine; Lymphedema; Internal medicine; Oncology; Cancer; Intensive care medicine; Family medicine; Breast cancer; Political science; Law","score_opus":0.035356857754343836,"score_gpt":0.376298638688677,"score_spread":0.3409417809343332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403393856","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003391061,0.15882637,0.016498484,0.65917176,0.12647179,0.0012470068,0.006574176,0.00028381796,0.027535513],"genre_scores_gemma":[0.057928536,0.2973613,0.107815005,0.35755187,0.11208848,0.005586305,0.021878175,0.00029878234,0.03949154],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.982679,0.0053777075,0.004879193,0.001241729,0.0047430727,0.0010793536],"domain_scores_gemma":[0.914212,0.03552541,0.005861589,0.0018266173,0.036502205,0.006072177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03091299,0.0013480136,0.0032417916,0.0035207893,0.0020801707,0.0032064144,0.0067120506,0.012500937,0.007732259],"category_scores_gemma":[0.052860774,0.0008557747,0.007148192,0.0019863641,0.0016679586,0.0021072668,0.0035991096,0.014985805,0.004365241],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040852025,0.00036768825,0.008067762,0.012834535,0.0009681171,0.0008644882,0.0005953692,0.0008743369,0.0008869791,0.007937314,0.725719,0.2404759],"study_design_scores_gemma":[0.0003828277,0.00031450452,0.016911369,0.051729307,0.0017047244,0.0019259712,0.0010471253,0.0007288576,0.0008610709,0.012886614,0.9113211,0.0001864238],"about_ca_topic_score_codex":0.008365626,"about_ca_topic_score_gemma":0.00802517,"teacher_disagreement_score":0.03091299,"about_ca_system_score_codex":0.0028852238,"about_ca_system_score_gemma":0.0172253,"threshold_uncertainty_score":0.16348553},"labels":[],"label_agreement":null},{"id":"W4403426072","doi":"10.1007/s12032-024-02533-z","title":"Modulation of the tumor microenvironment in non-muscle-invasive bladder cancer by OncoTherad® (MRB-CFI-1) nanoimmunotherapy: effects on tumor-associated macrophages, tumor-infiltrating lymphocytes, and monoamine oxidases","year":2024,"lang":"en","type":"editorial","venue":"Medical Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Tumor microenvironment; Hematology; Bladder cancer; Cancer research; Internal medicine; Bladder tumor; Tumor cells; Medicine; Monoamine neurotransmitter; Pathology; Cancer; Chemistry; Biology; Receptor; Serotonin","score_opus":0.003751702793627507,"score_gpt":0.24587692781359818,"score_spread":0.24212522501997066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403426072","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022709198,0.03294507,0.00043636293,0.038730513,0.9252375,0.000049106187,0.00008298157,0.00008773389,0.0022035916],"genre_scores_gemma":[0.0014550269,0.019801721,0.00023447775,0.030788984,0.9330566,0.000059263333,0.00004729059,0.00003165758,0.014525078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982665,0.00032347036,0.00019161147,0.0002516035,0.0008297505,0.00013707834],"domain_scores_gemma":[0.9963341,0.001568948,0.00023072788,0.0000906745,0.0010993448,0.0006761863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004716061,0.0032113546,0.0024036877,0.0015777225,0.0017192897,0.0031623167,0.0027665694,0.010744758,0.0041794805],"category_scores_gemma":[0.004822693,0.00093852007,0.002163593,0.00075496413,0.0015043168,0.0024645505,0.0010197836,0.017528031,0.0035577205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002731289,0.000052186806,0.000040557436,0.0005376235,0.000052117874,0.0002271202,0.000019377132,0.000059104328,0.0006326174,0.0006534088,0.9815516,0.015901081],"study_design_scores_gemma":[0.00036660527,0.00021101233,0.0006265196,0.00046196775,0.00019758378,0.00048755304,0.000039986608,0.0004319184,0.0009533793,0.001444479,0.9947463,0.00003274555],"about_ca_topic_score_codex":0.0017169196,"about_ca_topic_score_gemma":0.0045795906,"teacher_disagreement_score":0.010744758,"about_ca_system_score_codex":0.0023855201,"about_ca_system_score_gemma":0.0014823059,"threshold_uncertainty_score":0.024941146},"labels":[],"label_agreement":null},{"id":"W4403489458","doi":"10.1007/s12032-024-02442-1","title":"Essential components of the maintenance phase of complex decongestive therapy","year":2024,"lang":"en","type":"editorial","venue":"Medical Oncology","topic":"Pathogenesis and Treatment of Hiccups","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health; University of Alberta; Alberta Health Services","funders":"American Cancer Society","keywords":"Hematology; Phase (matter); Internal medicine; Medicine; Chemistry","score_opus":0.048938395039839246,"score_gpt":0.3998432980951781,"score_spread":0.35090490305533883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403489458","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048752583,0.019372573,0.00015522985,0.027181016,0.95170075,0.000021282143,0.000037857186,0.000029965271,0.0014525928],"genre_scores_gemma":[0.0003446297,0.009770675,0.000099845856,0.01074289,0.9758198,0.000015400974,0.000016758879,0.000011561183,0.0031783995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960525,0.0010362853,0.0006049633,0.00032843577,0.0017342833,0.0002435064],"domain_scores_gemma":[0.9809729,0.010740281,0.001078535,0.0004175805,0.0049756016,0.0018150567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070186616,0.0036606097,0.0039791507,0.0025112939,0.0021063937,0.005850601,0.0035821728,0.014670318,0.005595266],"category_scores_gemma":[0.018784067,0.0013322992,0.0027188242,0.0011268116,0.0027097731,0.0036603527,0.0012989442,0.026113901,0.0042890245],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012327736,0.000024753199,0.000041651747,0.0006458225,0.00005666059,0.00020167234,0.000018775758,0.000047123583,0.000110676505,0.00084452657,0.98662555,0.01125949],"study_design_scores_gemma":[0.00018182765,0.000097807584,0.00052151334,0.0010614822,0.00021231204,0.00046731572,0.000051852567,0.00025040534,0.00022938308,0.0017681058,0.9951266,0.000031393418],"about_ca_topic_score_codex":0.001945541,"about_ca_topic_score_gemma":0.005204337,"teacher_disagreement_score":0.014670318,"about_ca_system_score_codex":0.0036615576,"about_ca_system_score_gemma":0.003013896,"threshold_uncertainty_score":0.037118614},"labels":[],"label_agreement":null},{"id":"W4403490059","doi":"10.1007/s12032-024-02447-w","title":"The effect of compression therapies and therapeutic modalities on lymphedema secondary to cancer: a rapid review and evidence map","year":2024,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"Washington University School of Medicine in St. Louis; Stryker","keywords":"Medicine; Lymphedema; Modalities; Psychological intervention; Randomized controlled trial; Physical therapy; CINAHL; Massage; MEDLINE; Breast cancer; Intensive care medicine; Cancer; Internal medicine; Alternative medicine; Nursing; Pathology","score_opus":0.06455923188741099,"score_gpt":0.43201590876339296,"score_spread":0.367456676875982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403490059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016345542,0.9990336,0.00004567753,0.00018960529,0.00012346936,0.00010870808,0.000064149885,0.000003851464,0.00026754776],"genre_scores_gemma":[0.0015908341,0.9973175,0.0003037647,0.0003781709,0.00010804622,0.00014199076,0.00006138916,0.0000022858555,0.000096058255],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99464595,0.0014301721,0.0021185796,0.00036987374,0.0012581674,0.00017724377],"domain_scores_gemma":[0.96481985,0.027268916,0.0038095142,0.00036091186,0.0035019217,0.0002388357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009192847,0.0014987206,0.0076656532,0.015864296,0.000713265,0.0034090492,0.0020074989,0.0027975633,0.005513082],"category_scores_gemma":[0.02917755,0.00090306083,0.0058071585,0.015045187,0.000878109,0.0032807605,0.0013975338,0.0016053099,0.00063067063],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019096288,0.00002800172,0.00020603987,0.8829021,0.0020025691,0.00014951486,0.00013662268,0.00008502607,0.00028213602,0.0006269244,0.0036887687,0.10970135],"study_design_scores_gemma":[0.00014999883,0.0003090126,0.0018430968,0.92489296,0.019733153,0.0005398161,0.00023091634,0.00008068405,0.00021240514,0.00063906395,0.05133468,0.000034140976],"about_ca_topic_score_codex":0.004255783,"about_ca_topic_score_gemma":0.011497391,"teacher_disagreement_score":0.015864296,"about_ca_system_score_codex":0.004251326,"about_ca_system_score_gemma":0.0091888,"threshold_uncertainty_score":0.048616946},"labels":[],"label_agreement":null},{"id":"W4403628119","doi":"10.1007/s12032-024-02510-6","title":"Evidence-based recommendations regarding risk reduction practices for people at risk of or with breast cancer-related lymphedema: consensus from an expert panel","year":2024,"lang":"en","type":"editorial","venue":"Medical Oncology","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"American Cancer Society","keywords":"Breast cancer; Medicine; Lymphedema; Hematology; Oncology; Cancer; Internal medicine; Intensive care medicine; Family medicine","score_opus":0.07188742913772864,"score_gpt":0.4061091485451824,"score_spread":0.3342217194074537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403628119","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015207198,0.11435085,0.0014220467,0.21188426,0.66614,0.00050849764,0.0007741206,0.00009414966,0.00467396],"genre_scores_gemma":[0.0035966774,0.21258844,0.008024825,0.2493249,0.51577944,0.0010784055,0.0008952889,0.00018275296,0.008529332],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.972113,0.009244504,0.008094346,0.0014309527,0.008199755,0.0009174081],"domain_scores_gemma":[0.8191189,0.11071888,0.01048234,0.0019040151,0.052297954,0.0054778797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057767104,0.0029550453,0.0066623646,0.0063212644,0.0024291398,0.0076674307,0.0070702964,0.020037917,0.007721624],"category_scores_gemma":[0.1660051,0.0016661888,0.0075504277,0.0033834248,0.0023455557,0.005022012,0.002815384,0.029916389,0.005178128],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023040986,0.000039916238,0.00010824344,0.016163673,0.0008206179,0.00014728085,0.00019636241,0.000112298694,0.0001161749,0.0009092669,0.9363368,0.044818953],"study_design_scores_gemma":[0.0009613235,0.00009312896,0.00078814535,0.089899264,0.0036393823,0.00020424879,0.00025542645,0.00031663044,0.00024796973,0.003917801,0.8995691,0.000107403095],"about_ca_topic_score_codex":0.0060818903,"about_ca_topic_score_gemma":0.013159517,"teacher_disagreement_score":0.057767104,"about_ca_system_score_codex":0.004926095,"about_ca_system_score_gemma":0.014935036,"threshold_uncertainty_score":0.30550534},"labels":[],"label_agreement":null},{"id":"W4403992008","doi":"10.1007/s12032-024-02407-4","title":"Complete decongestive therapy phase 1: an expert consensus document","year":2024,"lang":"en","type":"editorial","venue":"Medical Oncology","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Quebec Breast Cancer Foundation","funders":"American Cancer Society","keywords":"Hematology; Phase (matter); Medicine; Medical physics; Internal medicine; Chemistry","score_opus":0.045432690046148375,"score_gpt":0.4312883459483686,"score_spread":0.38585565590222026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403992008","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000946614,0.06893976,0.0008926625,0.08912632,0.835263,0.0002535985,0.0004508082,0.000084328436,0.0048947977],"genre_scores_gemma":[0.0015770898,0.090469904,0.002279774,0.124518715,0.7674262,0.00053819676,0.00075500994,0.00016711958,0.012268072],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9837775,0.004599431,0.0032950782,0.0008733557,0.006509919,0.0009446348],"domain_scores_gemma":[0.93642086,0.028182382,0.0063202376,0.00090706616,0.023412094,0.0047573647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030302707,0.0027036374,0.0055447584,0.0041162795,0.002368854,0.007865212,0.0046856324,0.015336921,0.007920245],"category_scores_gemma":[0.042051986,0.0013691384,0.0050566914,0.0021199246,0.0021132655,0.0034790656,0.0026961584,0.020854618,0.008245864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011339223,0.000022294953,0.000023819814,0.001655522,0.00008084055,0.000056221354,0.000016814916,0.000053385786,0.00007646709,0.0002866019,0.98067045,0.016944092],"study_design_scores_gemma":[0.00048535137,0.000063997926,0.00025752358,0.007717526,0.00043047487,0.00019886826,0.000043129527,0.00014488216,0.0001986069,0.0010458735,0.9893741,0.00003968605],"about_ca_topic_score_codex":0.0035244015,"about_ca_topic_score_gemma":0.0082276305,"teacher_disagreement_score":0.030302707,"about_ca_system_score_codex":0.005206386,"about_ca_system_score_gemma":0.01608009,"threshold_uncertainty_score":0.16025794},"labels":[],"label_agreement":null},{"id":"W4408700959","doi":"10.1007/s12032-025-02672-x","title":"Correction to: The role of histamine and its receptors in breast cancer: from pathology to therapeutic targets","year":2025,"lang":"en","type":"erratum","venue":"Medical Oncology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. Georges-L.-Dumont University Hospital Centre; Atlantic Cancer Research Institute","funders":"","keywords":"Hematology; Medicine; Histamine; Breast cancer; Internal medicine; Receptor; Histamine receptor; Cancer; Pathology; Bioinformatics; Oncology; Biology","score_opus":0.005630322177287725,"score_gpt":0.24988485498400725,"score_spread":0.24425453280671952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408700959","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048539885,0.0010269491,0.00015979371,0.03214114,0.9652869,0.000011056195,0.00012146939,0.00006345338,0.001140713],"genre_scores_gemma":[0.0039893044,0.007180211,0.0014331964,0.0751528,0.8092153,0.000085840686,0.00039623064,0.00035726966,0.10218991],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967667,0.0006046643,0.0004948138,0.0004586781,0.0013341625,0.00034105458],"domain_scores_gemma":[0.98085326,0.004859955,0.0011048728,0.00091101916,0.010473703,0.0017972022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003370935,0.002255657,0.0017494522,0.0033245573,0.0024044572,0.0038924722,0.002918478,0.00867766,0.030627325],"category_scores_gemma":[0.03535726,0.00091508613,0.0016585545,0.0012737141,0.0023395882,0.0018579395,0.0014644943,0.012729501,0.020220332],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000393422,0.0000066415046,0.000039532133,0.00010143531,0.000009531042,0.00030623216,0.000011755985,0.000029279248,0.000048423084,0.00037075236,0.9949057,0.0041315216],"study_design_scores_gemma":[0.000051835028,0.00002438514,0.0004266406,0.0002662234,0.000038777132,0.0007935518,0.00004106366,0.00016000716,0.00024113288,0.00087509584,0.99705625,0.000025216521],"about_ca_topic_score_codex":0.010050082,"about_ca_topic_score_gemma":0.014167749,"teacher_disagreement_score":0.030627325,"about_ca_system_score_codex":0.004274649,"about_ca_system_score_gemma":0.004653029,"threshold_uncertainty_score":0.102458656},"labels":[],"label_agreement":null},{"id":"W4408721831","doi":"10.1007/s12032-025-02688-3","title":"Retraction Note: In vitro cytotoxicity and anti-cancer drug release behavior of methionine-coated magnetite nanoparticles as carriers","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Cytotoxicity; Magnetite; Nanoparticle; In vitro; Drug; Drug carrier; Magnetite Nanoparticles; Chemistry; Cancer; Pharmacology; Nanotechnology; Medicine; Cancer research; Materials science; Magnetic nanoparticles; Internal medicine; Biochemistry","score_opus":0.010387158572132345,"score_gpt":0.31260993333490505,"score_spread":0.3022227747627727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408721831","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046090884,0.0064903703,0.0011533964,0.13201118,0.84939784,0.00008674434,0.0005899999,0.0003485228,0.005312777],"genre_scores_gemma":[0.063705,0.01769347,0.005483296,0.102488354,0.5032543,0.0004684906,0.0015683222,0.0005369806,0.30480188],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827015,0.00014361249,0.00039750774,0.00018478936,0.00081658876,0.00018737654],"domain_scores_gemma":[0.9864986,0.0044899783,0.0012234772,0.00060365815,0.0064526973,0.00073153444],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002114041,0.00165128,0.0017345903,0.00075569144,0.0016083117,0.0011549818,0.002418003,0.007927285,0.0065105646],"category_scores_gemma":[0.018309947,0.0005649641,0.0010015444,0.0006941259,0.0011220381,0.0010093345,0.00080854,0.0076845596,0.007035497],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013547706,0.00003729722,0.00017672507,0.00044702512,0.000023590997,0.0010964437,0.00016143429,0.000121469806,0.006031675,0.001070163,0.9731953,0.017503344],"study_design_scores_gemma":[0.000047257807,0.0001412205,0.0028716405,0.00020213728,0.00006232798,0.0013201266,0.00016469714,0.0006875351,0.009195637,0.0005084275,0.9847281,0.00007097262],"about_ca_topic_score_codex":0.0051670596,"about_ca_topic_score_gemma":0.0052273287,"teacher_disagreement_score":0.99788594,"about_ca_system_score_codex":0.0023597414,"about_ca_system_score_gemma":0.0026386923,"threshold_uncertainty_score":0.021779954},"labels":[],"label_agreement":null},{"id":"W4408721832","doi":"10.1007/s12032-025-02693-6","title":"Retraction Note: Niosomes: a novel targeted drug delivery system for cancer","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Niosome; Hematology; Drug; Cancer drugs; Drug delivery; Medicine; Targeted drug delivery; Cancer; Pharmacology; Oncology; Internal medicine; Intensive care medicine; Nanotechnology; Biology","score_opus":0.07179405648295913,"score_gpt":0.47488518519386325,"score_spread":0.40309112871090413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408721832","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006023544,0.0083101215,0.00075056934,0.25197205,0.73579067,0.00004561918,0.0001970212,0.00015876336,0.002172842],"genre_scores_gemma":[0.010685665,0.019021513,0.003936808,0.34195033,0.5100467,0.00025145186,0.0003732784,0.00022659218,0.11350768],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996801,0.00034938168,0.0005995553,0.00039383012,0.0014726915,0.000383484],"domain_scores_gemma":[0.98587185,0.0056513404,0.0017264981,0.00054704375,0.0051599382,0.001043354],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035643869,0.0017273288,0.0020613365,0.00089738984,0.0022479724,0.0020759443,0.0031064718,0.018508537,0.00538993],"category_scores_gemma":[0.028108768,0.0008534969,0.0015851868,0.0009788045,0.002469088,0.00201565,0.001651846,0.029232625,0.0081176525],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003442906,0.000012433826,0.000060679205,0.00020859022,0.000017387087,0.0005346162,0.000052678093,0.000048465,0.00046253743,0.0007239727,0.9878285,0.010015822],"study_design_scores_gemma":[0.000026439075,0.00004090756,0.0004770391,0.00017968747,0.000048687136,0.00090529653,0.000059132195,0.00019951959,0.0009055145,0.00048367603,0.99664587,0.000028232422],"about_ca_topic_score_codex":0.0064025014,"about_ca_topic_score_gemma":0.007445067,"teacher_disagreement_score":0.99643564,"about_ca_system_score_codex":0.0045140954,"about_ca_system_score_gemma":0.0060977787,"threshold_uncertainty_score":0.032752216},"labels":[],"label_agreement":null},{"id":"W4408766124","doi":"10.1007/s12032-025-02692-7","title":"Retraction Note: Molecular and therapeutic effect of CRISPR in treating cancer","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Hematology; CRISPR; Medicine; Internal medicine; Cancer; Computational biology; Biology; Oncology; Genetics; Gene","score_opus":0.003961528702442092,"score_gpt":0.3733236946983364,"score_spread":0.3693621659958943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408766124","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029129925,0.0033800262,0.0004344081,0.2025227,0.7901449,0.00002625481,0.00022365569,0.00012307243,0.0028536697],"genre_scores_gemma":[0.0074726115,0.010536614,0.0026396343,0.20332646,0.6521506,0.00016008368,0.0005564268,0.00024802945,0.12290956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963433,0.00044142923,0.00066480675,0.00039234653,0.0016990112,0.00045903257],"domain_scores_gemma":[0.97502553,0.0101473555,0.0015615454,0.0009518841,0.009928561,0.0023851132],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040237736,0.0018348667,0.0017657888,0.0015158158,0.0021374158,0.0024272038,0.0034930147,0.015946083,0.013173834],"category_scores_gemma":[0.035372596,0.0008202322,0.0015758496,0.0011428822,0.0021570462,0.001795867,0.0015218896,0.024526406,0.011523342],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025961492,0.000007464335,0.00004235218,0.00009449938,0.0000101269525,0.00028169528,0.000028432365,0.000030507723,0.00026809482,0.0006401976,0.99209964,0.0064711305],"study_design_scores_gemma":[0.000026095122,0.000034969053,0.00074139104,0.00014387208,0.000032692584,0.0007911482,0.000056217992,0.00015530326,0.0006044617,0.0005722935,0.9968144,0.000027152544],"about_ca_topic_score_codex":0.0055426294,"about_ca_topic_score_gemma":0.007642488,"teacher_disagreement_score":0.9840539,"about_ca_system_score_codex":0.0034877537,"about_ca_system_score_gemma":0.0044657695,"threshold_uncertainty_score":0.0440709},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4408921736","doi":"10.1007/s12032-025-02695-4","title":"Vitamin D3 and its active form calcitriol suppress erythroleukemia through upregulation of CHAC1 and downregulation of NOTCH1","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Calcitriol receptor; Downregulation and upregulation; Calcitriol; Cell growth; Cancer research; Cell cycle; Leukemia; Gene knockdown; Growth inhibition; Biology; Chemistry; Apoptosis; Cell biology; Vitamin D and neurology; Endocrinology; Immunology; Biochemistry; Gene","score_opus":0.01874353124716123,"score_gpt":0.3669770887246786,"score_spread":0.3482335574775174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408921736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866731,0.0068541146,0.0011636902,0.00032778157,0.000051465602,0.000053583677,0.00026052052,0.00006448822,0.0045510395],"genre_scores_gemma":[0.994795,0.001116524,0.00090000103,0.00008312091,0.000011535546,0.000023182505,0.00016663395,0.000007674107,0.0028964083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998406,0.000036616668,0.000016296874,0.000019334422,0.000052585834,0.00003452174],"domain_scores_gemma":[0.99984777,0.00003343007,0.000039987284,0.000015385627,0.000023586988,0.000039918472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018527979,0.00015459568,0.00019390638,0.00036271024,0.00017401091,0.00036459859,0.00022622202,0.00024853298,0.0020956604],"category_scores_gemma":[0.00024855716,0.00008352447,0.00023777035,0.00019577528,0.0002643666,0.000170756,0.00018392359,0.00040899665,0.00020333544],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025826513,0.0001783893,0.0015527839,0.00008758854,0.000037256275,0.00015863866,0.000036096524,0.00008892681,0.982093,0.00039873086,0.00017673016,0.012609311],"study_design_scores_gemma":[0.00033971926,0.0013910197,0.020079885,0.000017794959,0.0000796889,0.00066951715,0.00017122214,0.00069411204,0.9652627,0.00023274797,0.011051302,0.000010326814],"about_ca_topic_score_codex":0.0014560443,"about_ca_topic_score_gemma":0.0026062068,"teacher_disagreement_score":0.0020956604,"about_ca_system_score_codex":0.00037220528,"about_ca_system_score_gemma":0.00046693036,"threshold_uncertainty_score":0.0070106983},"labels":[],"label_agreement":null},{"id":"W4409622108","doi":"10.1007/s12032-025-02731-3","title":"Retraction Note: TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Hematology; Agonist; Medicine; Immunotherapy; Antagonist; Cancer immunotherapy; Cancer; Internal medicine; Pharmacology; Receptor","score_opus":0.013129164818774639,"score_gpt":0.347761619960803,"score_spread":0.3346324551420284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409622108","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025646563,0.008466637,0.0003849603,0.26016366,0.72858495,0.000023901031,0.00013401633,0.000058196303,0.001927274],"genre_scores_gemma":[0.0036883464,0.010369582,0.0009867406,0.14924958,0.79818636,0.00006479437,0.00014809727,0.00006858553,0.03723789],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714655,0.0004559219,0.00060557586,0.00033347687,0.0011293541,0.00032910332],"domain_scores_gemma":[0.98057896,0.008070196,0.0014450006,0.0006374094,0.007518122,0.0017502569],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0037504663,0.0020631244,0.0026669088,0.0014269107,0.0019083711,0.0026041747,0.0026740765,0.019296244,0.0075577674],"category_scores_gemma":[0.027632136,0.0009316027,0.0016065922,0.0011735327,0.0020827083,0.002668492,0.0012890268,0.028921613,0.009718053],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000309452,0.000005996405,0.000050024613,0.00010358996,0.000009252529,0.00035793008,0.000017843018,0.00003065415,0.00015358081,0.00042878493,0.99143547,0.007375877],"study_design_scores_gemma":[0.000036175486,0.00003886215,0.0006338233,0.00020193408,0.000038079786,0.001276287,0.000048854537,0.00023652092,0.00028554586,0.0006684243,0.99650913,0.00002634331],"about_ca_topic_score_codex":0.0037962496,"about_ca_topic_score_gemma":0.005842941,"teacher_disagreement_score":0.9807038,"about_ca_system_score_codex":0.0036854604,"about_ca_system_score_gemma":0.0036874271,"threshold_uncertainty_score":0.026740015},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4409622218","doi":"10.1007/s12032-025-02733-1","title":"Retraction Note to: Anti-cancer activity of human gastrointestinal bacteria","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Hematology; Cancer; Internal medicine; Bacteria; Medicine; Gastrointestinal cancer; Oncology; Biology; Colorectal cancer; Genetics","score_opus":0.017805164576556898,"score_gpt":0.41184222866831127,"score_spread":0.3940370640917544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409622218","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047854986,0.0054608737,0.00040842345,0.17387414,0.81620854,0.000037622845,0.00027544092,0.00012678107,0.0031296255],"genre_scores_gemma":[0.010500639,0.013682142,0.0026097284,0.19535649,0.65700865,0.00015920159,0.0006340183,0.0002258145,0.11982336],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972276,0.00031264313,0.00060359197,0.00030991773,0.0011806875,0.0003656105],"domain_scores_gemma":[0.98195446,0.0071354066,0.0018222504,0.0009016631,0.0067581506,0.0014281431],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023848123,0.0022289653,0.0020342255,0.0013634189,0.0019771154,0.0022434583,0.0029886956,0.0130952215,0.012892595],"category_scores_gemma":[0.026331494,0.00083936914,0.001749135,0.0010468728,0.001751061,0.0015833059,0.0014225425,0.02066515,0.013008822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048778074,0.000012155402,0.00007446122,0.00017871536,0.000013586777,0.00047263133,0.000042518062,0.00003200366,0.00043238292,0.00053402584,0.98910284,0.0090558175],"study_design_scores_gemma":[0.000022679225,0.00004409811,0.0009196517,0.00018477307,0.00003223457,0.0006538217,0.00007016748,0.00013684499,0.0006632204,0.00038669037,0.9968646,0.000021175218],"about_ca_topic_score_codex":0.0056220996,"about_ca_topic_score_gemma":0.0054093753,"teacher_disagreement_score":0.9869048,"about_ca_system_score_codex":0.0029539245,"about_ca_system_score_gemma":0.0042149955,"threshold_uncertainty_score":0.04313004},"labels":[{"model":"gemma","categories":["research_integrity"],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch","research_integrity"],"domain":"methods","study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4409788861","doi":"10.1007/s12032-025-02732-2","title":"Retraction Note: Artificial intelligence and machine learning in precision and genomic medicine","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Hematology; Artificial intelligence; Precision medicine; Computer science; Machine learning; Internal medicine; Medical physics; Medicine; Pathology","score_opus":0.026851474927089374,"score_gpt":0.37187913617071205,"score_spread":0.34502766124362266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409788861","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007746608,0.0015420339,0.0002700711,0.31593278,0.68114537,0.000012045881,0.00015198876,0.000064244916,0.00080394914],"genre_scores_gemma":[0.0025845875,0.0033487182,0.0013361062,0.33868682,0.6212557,0.000102315265,0.00020630697,0.00022610961,0.032253355],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896115,0.001806799,0.0023512796,0.0012262709,0.0040103733,0.0009937685],"domain_scores_gemma":[0.892407,0.05660125,0.0043966016,0.004215295,0.03818894,0.00419088],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00998612,0.0025176315,0.0031243288,0.0032457307,0.0045333654,0.0054725306,0.0059794514,0.037759162,0.017306523],"category_scores_gemma":[0.13547757,0.0016392347,0.003219202,0.0026567779,0.005205243,0.0040366356,0.0026250328,0.060381822,0.018285356],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001129496,0.0000036666672,0.000028823551,0.000051902338,0.000007828417,0.000103598424,0.000028305385,0.00001513045,0.000035391484,0.0005760762,0.9971806,0.001957479],"study_design_scores_gemma":[0.000042558757,0.0000245734,0.0007739454,0.0004279649,0.000046698835,0.00054934726,0.00014915095,0.00029935592,0.00021842564,0.0018122022,0.99561226,0.00004345071],"about_ca_topic_score_codex":0.017743338,"about_ca_topic_score_gemma":0.020195555,"teacher_disagreement_score":0.9622408,"about_ca_system_score_codex":0.0062309937,"about_ca_system_score_gemma":0.008485877,"threshold_uncertainty_score":0.057896137},"labels":[{"model":"gemma","categories":["research_integrity"],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4410253921","doi":"10.1007/s12032-025-02758-6","title":"Reducing the effective dosage of Mitomycin C on a high-grade bladder cancer cell line through combination with selenium nanoparticles: An in vitro study","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Selenium in Biological Systems","field":"Nursing","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; Thunder Bay Regional Research Institute","funders":"","keywords":"Hematology; Selenium; Mitomycin C; In vitro; Cancer cell lines; Bladder cancer; Internal medicine; Oncology; Cancer; Medicine; Pharmacology; Cancer research; Chemistry; Cancer cell; Surgery; Biochemistry","score_opus":0.016729932369968906,"score_gpt":0.33381144996831147,"score_spread":0.3170815175983426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410253921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945081,0.0025161987,0.001454459,0.00010267416,0.000066610184,0.000043221025,0.00013272522,0.000029700983,0.0011463326],"genre_scores_gemma":[0.99347323,0.0019997112,0.0019991219,0.000050890994,0.000018247018,0.000042538824,0.0001724435,0.00001063848,0.0022331327],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997646,0.000048300146,0.000026143989,0.000043266253,0.000078889156,0.00003886285],"domain_scores_gemma":[0.9998338,0.000062427804,0.00002298396,0.00002034387,0.000045062938,0.000015359361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030331503,0.00039021904,0.0005468417,0.00025978958,0.00024516627,0.00024076956,0.00030346168,0.00050677406,0.0009907259],"category_scores_gemma":[0.00021489144,0.0001893482,0.00052202377,0.00031079655,0.00018155445,0.00028807533,0.00017776208,0.00046469603,0.00017008002],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026339543,0.000239268,0.00026544454,0.00012741782,0.000023460714,0.00006737237,0.000051250925,0.00024301182,0.9957658,0.000038504986,0.000083368424,0.002831723],"study_design_scores_gemma":[0.000015035964,0.0019606666,0.0014955822,0.0000061985747,0.000051395218,0.00006953793,0.00005500074,0.0007483993,0.99460137,0.000010079114,0.0009809324,0.0000059044805],"about_ca_topic_score_codex":0.0018325443,"about_ca_topic_score_gemma":0.0028169856,"teacher_disagreement_score":0.0018325443,"about_ca_system_score_codex":0.00022658877,"about_ca_system_score_gemma":0.00024563586,"threshold_uncertainty_score":0.0036437511},"labels":[],"label_agreement":null},{"id":"W4411695433","doi":"10.1007/s12032-025-02839-6","title":"Anticancer potential of daidzin: a comprehensive literature review","year":2025,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Daidzin; Hematology; Medicine; Traditional medicine; Internal medicine; Pharmacology; Daidzein","score_opus":0.03955794150584915,"score_gpt":0.47298043010966656,"score_spread":0.43342248860381744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411695433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001580401,0.9994356,0.00003307416,0.0000863936,0.00003882258,0.000007257984,0.00005865144,0.0000028717645,0.00017932506],"genre_scores_gemma":[0.00066979637,0.9989261,0.00011126959,0.00011999647,0.0000352412,0.0000047546364,0.000044431945,5.658698e-7,0.000087868684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997243,0.000044599787,0.0000875963,0.000051975025,0.00007061791,0.000020866295],"domain_scores_gemma":[0.99919754,0.0004556609,0.00018152996,0.00001468171,0.00011949911,0.00003113357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076314574,0.0009741519,0.00250615,0.004958169,0.00031426022,0.0012939076,0.000872871,0.00090767944,0.0052162195],"category_scores_gemma":[0.0015135024,0.0004750229,0.001680853,0.0052286554,0.0003390591,0.0012244998,0.0008791458,0.0010519505,0.0006575521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003972459,0.00012850555,0.0007881737,0.3633178,0.0018376944,0.00043976962,0.0001649015,0.00036463642,0.002517041,0.0011461388,0.01655376,0.61234444],"study_design_scores_gemma":[0.00028543838,0.0006034299,0.007496551,0.12953436,0.019970773,0.0028467814,0.00046058986,0.0002950009,0.0016498548,0.0019742628,0.83475345,0.00012939173],"about_ca_topic_score_codex":0.0028207789,"about_ca_topic_score_gemma":0.00794036,"teacher_disagreement_score":0.0052162195,"about_ca_system_score_codex":0.0006516544,"about_ca_system_score_gemma":0.0020338248,"threshold_uncertainty_score":0.017449975},"labels":[],"label_agreement":null},{"id":"W4412648008","doi":"10.1007/s12032-025-02941-9","title":"Epigenetic reprogramming of mast and cancer cells modifies tumor-promoting cytokine networks","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Reprogramming; Mast (botany); Epigenetics; Cytokine; Hematology; Cancer; Cancer research; Biology; Mast cell; Immunology; Medicine; Genetics; Gene","score_opus":0.009189016520813803,"score_gpt":0.2696924671615731,"score_spread":0.2605034506407593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412648008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98459977,0.003971237,0.0044935364,0.00034976265,0.00013160353,0.000026011234,0.00039096392,0.00006133045,0.0059757777],"genre_scores_gemma":[0.9965018,0.0007076944,0.00056664844,0.00010866044,0.000020510934,0.000010465814,0.00014677478,0.000008981747,0.00192836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998609,0.000023777213,0.0000056307767,0.000041371026,0.000028122035,0.0000402591],"domain_scores_gemma":[0.9999224,0.000015468211,0.0000258748,0.000012376787,0.000009928899,0.000013972499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013903686,0.00010753193,0.00012656614,0.000121882054,0.00013679286,0.00040226756,0.0001385489,0.00022324071,0.0027055587],"category_scores_gemma":[0.0002227232,0.00008229539,0.00015892509,0.00010303834,0.00017609935,0.00019071477,0.00025293537,0.00029678244,0.00027990286],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030821637,0.000026105014,0.0036093132,0.000058957627,0.000024957493,0.00020152058,0.000100934616,0.00012306964,0.9825697,0.0012246533,0.00019693405,0.011555746],"study_design_scores_gemma":[0.00008842488,0.0009006702,0.13366,0.000056442725,0.00017120781,0.0017158971,0.00085740467,0.0020103033,0.81828654,0.0019570435,0.040272407,0.000023786526],"about_ca_topic_score_codex":0.00020131106,"about_ca_topic_score_gemma":0.0005117535,"teacher_disagreement_score":0.0027055587,"about_ca_system_score_codex":0.00019307726,"about_ca_system_score_gemma":0.00012553355,"threshold_uncertainty_score":0.009050965},"labels":[],"label_agreement":null},{"id":"W7117295989","doi":"10.1007/s12032-025-03155-9","title":"Therapeutic potential of natural triterpenoids in liver cancer","year":2025,"lang":"en","type":"article","venue":"Medical Oncology","topic":"Natural product bioactivities and synthesis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Sorafenib; Liver cancer; Cirrhosis; Cancer; Malignancy; Hepatocellular carcinoma; Immune system","score_opus":0.007145747892532476,"score_gpt":0.3019036451075389,"score_spread":0.29475789721500645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117295989","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71466494,0.2163825,0.022113958,0.0025078459,0.0004158702,0.00024862363,0.0013147048,0.00029528196,0.042056285],"genre_scores_gemma":[0.9291913,0.05409235,0.005202018,0.00036344695,0.00009079417,0.000047976486,0.000388626,0.000025589312,0.010597901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999964,0.000011598826,0.0000020602492,0.000005324244,0.0000063538687,0.000010685104],"domain_scores_gemma":[0.9999554,0.000010008304,0.000009091797,0.000006592125,0.000006944037,0.000011964353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001682403,0.00025614366,0.00017765448,0.00041767198,0.000120223674,0.00033220212,0.00013299183,0.0001913678,0.0033412457],"category_scores_gemma":[0.00008879555,0.00006377195,0.00022497018,0.00026608005,0.00020463389,0.00023187471,0.00018396358,0.00048313447,0.0005762557],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084641663,0.00024628628,0.0004476798,0.00072450377,0.00003478711,0.000705653,0.00010203498,0.0010992736,0.89119667,0.0060296687,0.00067319686,0.09789385],"study_design_scores_gemma":[0.00019223044,0.002826599,0.0026191527,0.00014949549,0.00012752187,0.0021008926,0.00016569276,0.0009228821,0.90605503,0.0034058227,0.08140394,0.000030680698],"about_ca_topic_score_codex":0.00020138515,"about_ca_topic_score_gemma":0.00036709334,"teacher_disagreement_score":0.0033412457,"about_ca_system_score_codex":0.00019361834,"about_ca_system_score_gemma":0.00021070178,"threshold_uncertainty_score":0.011177599},"labels":[],"label_agreement":null}]}